WO1993023398A1 - Substituted pyrido[1,2-a]pyrimidinone derivatives as fungicides - Google Patents

Substituted pyrido[1,2-a]pyrimidinone derivatives as fungicides Download PDF

Info

Publication number
WO1993023398A1
WO1993023398A1 PCT/US1993/004188 US9304188W WO9323398A1 WO 1993023398 A1 WO1993023398 A1 WO 1993023398A1 US 9304188 W US9304188 W US 9304188W WO 9323398 A1 WO9323398 A1 WO 9323398A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
propyl
haloalkyl
alkoxy
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1993/004188
Other languages
French (fr)
Inventor
Thomas Paul Selby
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EIDP Inc
Original Assignee
EI Du Pont de Nemours and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EI Du Pont de Nemours and Co filed Critical EI Du Pont de Nemours and Co
Priority to EP93911028A priority Critical patent/EP0640083A1/en
Publication of WO1993023398A1 publication Critical patent/WO1993023398A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Definitions

  • This invention relates to certain substituted pyrido [1,2-a]pyrimidinone compounds useful as
  • fungicides their agriculturally suitable salts and compositions, and methods of their use as general or selective fungicides, in particular for the control of wheat powdery mildew both preventive and curativeUrban et al., Helv. Chim . Acta, 1970, 53, 905, disclose pyrido [1,2-a]pyrimidinones of Formula i and their use as analgesics and antiinflammatory agents.
  • W is O; S or NH;
  • This invention comprises compounds of Formula I including all geometric and stereoisomers, N-oxides, agriculturally-suitable salts thereof, agricultural compositions containing them and method of use of said compounds, salts, or compositions as fungicides,
  • Q is O or S
  • W is O; S; S(O); S(O) 2 ; NH; or NR 9 ;
  • X is CR 3 or N
  • Y is CR 4 or N
  • R 1 is C 1 -C 18 alkyl; C 3 -C 7 cycloalkyl; C 2 -C 18
  • alkenyl C 2 -C 18 alkynyl; C 1 -C 18 haloalkyl; C 2 -C 18 haloalkenyl; C 2 -C 18 haloalkynyl; C 2 -C 18 alkoxyalkyl; C 2 -C 18 alkylthioalkyl; C 2 -C 18 alkylsulfinylalkyl; C 2 -C 18 alkylsulfonylalkyl;
  • C 4 -C 18 haloalkynyloxyalkyl C 4 -C 18 alkoxyalkenyl; C 4 -C 18 alkoxyalkynyl; C 4 -C 18 alkylthio alkenyl; C 4 -C 18 alkylthioalkynyl; C 4 -C 18 trialkylsilylalkyl; C 1 -C 18 alkyl substituted with NR 8 R 10 , cyano, or nitro; C 1 -C 8 alkyl substituted with CO 2 R 8 ; C 1 -C 18 alkoxy; C 1 -C 18 haloalkoxy; C 3 -C 18 alkynyloxy; C 3 -C 18 alkenyloxy; C 1 -C 18 alkylthio; C 3 -C 18 alkenylthio; or C 3 -C 18 alkynylthio;
  • R 2 is C 1 -C 18 alkyl; C 3 -C 7 cycloalkyl; C 3 -C 18
  • alkenyl C 3 -C 18 alkynyl; C 1 -C 18 haloalkyl;
  • nitroalkyl C 1 -C 8 alkyl substituted with CO 2 R 8 ; or phenyl, benzyl, or phenethyl each optionally substituted on the phenyl ring with R 13 ; or
  • R 1 and R 2 can be taken together along with the
  • R 3 and R 5 are each independently hydrogen; halogen;
  • R 4 and R 6 are each independently hydrogen; halogen;
  • R 7 is C 1 -C 4 alkyl or C 1 -C 4 haloalkyl
  • R 8 and R 9 are each independently C 1 -C 4 alkyl
  • R 10 and R 11 are each independently H or C 1 -C 4 alkyl;
  • R 12 is C 1 -C 8 alkyl;
  • R 8' and R 10 can be taken together to form -CH 2 CH 2 CH 2 CH 2 -, -CH 2 (CH 2 ) 3 CH 2 -,
  • R 13 is halogen; C 1 -C 4 alkyl, C 1 -C 4 alkoxy, or C 1 -C 4 haloalkyl;
  • R 5 and R 6 is equal to or less than 16; iii) the total number of nitrogen atoms
  • R 3 and R 4 are not both hydrogen; and v) X and Y are not both nitrogen.
  • Preferred for reasons of ease of synthesis or greater fungicidal activity are compounds of Formula I, denoted as Preferred 1, wherein: W is O; S; NH; or NR 9 ;
  • X is CR 3 ;
  • Y is CR 4 ;
  • R 1 is C 1 -C 8 alkyl; C 2 -C 8 alkenyl; C 2 -C 8
  • alkynyl C 1 -C 8 haloalkyl; C 2 -C 8
  • haloalkenyl C 2 -C 8 alkoxyalkyl; C 2 -C 8 alkylthioalkyl; C 4 -C 8 cycloalkylalkyl; C 2 -C 8 cyanoalkyl; C 1 -C 8 alkoxy; C 1 -C 18 haloalkoxy; C 3 -C 8 alkenyloxy; C 3 -C 8 alkenylthio; or C 4 -C 8 alkenyloxyalkyl;
  • R 2 is C 1 -C 8 alkyl; C 2 -C 8 alkenyl; C 2 -C 8
  • alkynyl C 1 -C 8 haloalkyl; C 2 -C 8
  • R 4 and R 6 are each independently hydrogen; halogen; C 1 -C 8 alkyl; C 3 -C 8 cycloalkyl; C 1 -C 8 haloalkyl; C 1 -C 8 alkoxy; C 1 -C 8 haloalkoxy; C 1 -C 8 alkylthio; C 1 -C 8 alkylsulfonyl; C 2 -C 8 alkoxyalkyl; C 2 -C 8 alkylthioalkyl; C 4 -C 8 cycloalkylalkyl; C 3 -C 8 trialkylsilyl; or cyano.
  • W is O; S; NH; or NMe
  • R 1 is C 1 -C 8 alkyl; C 2 -C 8 alkenyl; C 2 -C 8
  • alkynyl C 1 -C 8 haloalkyl; C 2 -C 8 halo- alkenyl; C 1 -C 8 alkoxy; C 2 -C 8 alkoxyalkyl; or C 3 -C 8 alkenyloxy;
  • R 2 is C 1 -C 8 alkyl; C 2 -C 8 alkenyl; C 2 -C 8
  • R 4 and R 6 are each independently hydrogen; halogen; C 1 -C 8 alkyl; C 1 -C 8 haloalkyl; C 1 -C 8 alkoxy; C 1 -C 8 haloalkoxy; C 3 -C 8 trialkylsilyl; or cyano.
  • R 1 is C 1 -C 8 alkyl; C 2 -C 8 alkenyl; C 2 -C 8
  • alkynyl C 1 -C 8 haloalkyl; or C 2 -C 8 haloalkenyl
  • R 2 is C 1 -C 8 alkyl; C 2 -C 8 alkenyl; C 2 -C 8
  • alkynyl C 1 -C 8 haloalkyl; C 2 -C 8
  • R 4 and R 6 are each independently hydrogen; halogen; C 1 -C 8 alkyl; C 1 -C 8 haloalkyl; C 1 -C 8 alkoxy; or C 1 -C 8 haloalkoxy.
  • alkyl used either alone or in compound words such as “alkylthio,” “haloalkyl,” or “alkylthioalkyl” denotes straight-chain or branched alkyl; e.g., methyl, ethyl, n-propyl, i-propyl, or the different butyl, pentyl, hexyl, etc. isomers.
  • Cycloalkyl denotes cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl.
  • cycloalkyl oxyalkyl denotes the cycloalkyl groups linked through an oxygen atom to an alkyl chain. Examples include cyclopentyloxymethyl and cyclohexyloxybutyl.
  • cycloalkylthioalkyl are the cycloalkyl groups linked through a sulfur atom to an alkyl chain; e.g., cyclopropylthiopentyl.
  • Cycloalkylalkyl denotes a
  • cycloalkyl ring attached to a branched or straight-chain alkyl; e.g. cyclopropylmethyl and cyclohexylbutyl.
  • Alkenyl denotes straight chain or branched alkenes; e.g., 1-propenyl, 2-propenyl, 3-propenyl and the different butenyl , pentenyl, hexenyl, etc.
  • Alkenyl also denotes polyenes such as
  • Alkynyl denotes straight chain or branched alkynes; e.g., ethynyl, 1-propynyl, 3-propynyl and the different butynyl, pentynyl, hexynyl, etc. isomers. "Alkynyl” can also denote moieties comprised of
  • Alkoxy denotes methoxy, ethoxy, n-propyloxy, isopropyloxy and the different butoxy, pentoxy,
  • alkoxyalkenyl and “alkoxyalkynyl” denoted groups in which the alkoxy group is bonded throught the oxygen atom to an alkenyl or alkynyl group, respectively. Examples include
  • CH 3 OCH 2 CH CH and (CH 3 ) 2 CHOCH 2 C ⁇ CCH 2 .
  • alkenylthioalkyl denotes the alkenylthio moieties bonded to an alkyl group.
  • H 2 C CHCH 2 SCH(CH 3 ) CH(CH 3 ) and
  • Alkynyloxy denotes straight or branched
  • alkynyloxy moieties examples include HC ⁇ CCH 2 O,
  • Alkynyloxyalkyl denotes alkynyloxy moieties bonded to alkyl groups; e.g.,
  • Alkynylthioalkyl denotes alkynylthio moieties bonded to alkyl groups.
  • Example include CH 3 C ⁇ CCH 2 SCH 2 CH 2 and CH 3 C ⁇ CCH 2 CH 2 SCH(CH 3 )CH 2 .
  • Alkylthio denotes methylthio, ethylthio, and the different propylthio, butylthio, pentylthio and
  • alkylthioalkyl denotes alkylthio groups attached to an alkyl chain; e.g.,
  • Alkylsulfinyl denotes both enantiomers of an alkylsulfinyl group. For example, CH 3 S(O), CH 3 CH 2 S(O), CH 3 CH 2 CH 2 S(O), (CH 3 ) 2 CHS(O) and the different
  • Alkylsulfinylalkyl denotes alkylsulfinyl groups attached to an alkyl chain; e.g., CH 3 CH 2 S(O)CH 2 CH(CH 3 ) and (CH 3 ) 2 CHS(O)CH 2 .
  • alkylsulfonyl examples include CH 3 S(O) 2 ,
  • alkylsulfonylalkyl denotes alkylsulfonyl groups attached to an alkyl chain; e.g.,
  • halogen either alone or in compound words such as “haloalkyl”, denotes fluorine, chlorine, bromine or iodine. Further, when used in compound words such as “haloalkyl”, said alkyl may be partially or fully substituted with halogen atoms which may be the same or different. Examples of “haloalkyl” include F 3 C, ClCH 2 , CF 3 CH 2 and CF 3 CF 2 . Examples of
  • haloalkynyl examples include HC ⁇ CCHCl, CF 3 C ⁇ C,
  • Haloalkynyloxyalkyl denotes haloalkynyl groups bonded through an oxygen atom to an alkyl moiety. Examples include CF 3 C ⁇ CCH 2 OCH 2 CH 2 ,
  • haloalkoxy examples include CF 3 O, CCl 3 CH 2 O, CF 2 HCH 2 CH 2 O and CF 3 CH 2 O.
  • Haloalkoxyalkyl denotes haloalkoxy groups bonded to straight-chain or branched alkyl groups; e.g.,
  • Trialkylsilyl designates a group with three alkyl groups bonded to silicon; e.g., (CH 3 ) 3 Si and
  • trialkylsilyl groups bonded to another straight-chain or branched alkyl group examples include (CH 3 ) 3 SiCH 2 and t-Bu(CH 3 ) 2 SiCH 2 CH(CH 3 )CH 2 .
  • C i -C j The total number of carbon atoms in a substituent group is indicated by the "C i -C j " prefix where i and j are numbers from 1 to 20.
  • C 1 -C 3 alkyl-sulfonyl designates methylsulfonyl through propyl-sulfonyl
  • C 2 alkoxyalkoxy designates CH 3 OCH 2 O
  • C 3 alkoxyalkoxy designates, for example, CH 3 OCH 2 CH 2 O or
  • CH 3 CH 2 OCH 2 O; and C 4 alkoxyalkoxy designates the various isomers of an alkoxy group substituted with a second alkoxy group containing a total of 4 carbon atoms, examples including CH 3 CH 2 CH 2 OCH 2 O, and CH 3 CH 2 OCH 2 CH 2 O.
  • alkoxyalkyl examples include CH 3 OCH 2 , CH 3 OCH 2 CH 2 , CH 3 CH 2 OCH 2 , CH 3 CH 2 CH 2 CH 2 OCH 2 and CH 3 CH 2 OCH 2 CH 2 .
  • Compounds of Formula I can be prepared using one or more of the reactions and techniques described in
  • Formula lb wherein G is S with a suitable oxidizing agent such as meta-chloroperoxybenzoic acid furnishes products of Formula Ic.
  • bromination of compounds of Formula Ig with bromine or N-bromosuccinimide (NBS) yields brominated adducts of Formula VII which can be coupled with stannanes of Formula R 14 Sn (C H3 ) 3 in the presence of a palladium catalyst such as tetrakis(triphenylphosphine)-palladium(O) or bis(triphenylphosphine)palladium (II) chloride to afford products of Formula If.
  • a palladium catalyst such as tetrakis(triphenylphosphine)-palladium(O) or bis(triphenylphosphine)palladium (II) chloride
  • Bromoheterocycles of Formula VII can also be coupled with terminal alkynes using palladium catalysis in the presence of base (such as triethylamine) and cuprous iodide.
  • base such as triethylamine
  • Salts of compounds of Formula I can be formed by treating the free base of Formula I with strong acids such as hydrochloric or sulfuric acid.
  • N-oxides of compounds of Formula I can be made by oxidizing
  • n - is normal CN - is cyano
  • Me - is methyl S(O)Me - is methylsulfinyl Et - is ethyl S(O) 2 Me - is methylsulfonyl Ph - is phenyl
  • compositions of this invention comprise an effective amount of a compound of Formula I as defined above and at least one of (a) a surfactant, (b) an organic solvent, and (c) at least one solid or liquid diluent
  • useful formulations include dusts, granules, pellets, solutions, suspensions, emulsions, wettable powders, emulsifiable concentrates, dry flowables and the like, consistent with the physical properties of the active ingredient, mode of application and environmental factors such as soil type, moisture and temperature.
  • Sprayable formulations can be extended in suitable media and used at spray volumes from about one to several hundred liters per hectare. High strength compositions are primarily used as intermediates for further formulation.
  • the formulations will typically contain effective amounts of active ingredient, diluent and surfactant within the following approximate ranges which add up 100 weight percent.
  • Weight Percent weight percent
  • Fine solid compositions are made by blending and, usually, grinding as in a hammer mill or fluid energy mill.
  • Water-dispersible granules can be produced be agglomerating a fine powder composition; see for example, Cross et al., Pesticide Formulations, Washington, D.C., 1988, pp 251-259.
  • Suspensions are prepared by wet-milling; see, for example, U.S.
  • Granules and pellets can be made by
  • Pellets can be prepared as described in U.S. 4,172,714. Water-dispersible and water-soluble granules can be prepared as taught in DE 3,246,493.
  • Compound 3 65.0% dodecylphenol polyethylene glycol ether 2.0% sodium ligninsulfonate 4.0% sodium silicoaluminate 6.0% montmorillonite (calcined) 23.0%.
  • Compound 3 25.0% anhydrous sodium sulfate 10.0% crude calcium ligninsulfonate 5.0% sodium alkylnaphthalenesulfonate 1.0% calcium/magnesium bentonite 59.0%.
  • the compounds and compositions of this invention are useful as plant disease control agents.
  • the present invention therefore further comprises a method for controlling plant diseases caused by fungal plant pathogens comprising applying to the plant or portion thereof to be protected, to the media in which the plant to be protected is growing, or to the plant seed or seedling an effective amount of a compound of
  • Formula I an N-oxide thereof, an agriculturally suitable salt thereof, or a fungicidal composition containing said compound, N-oxide, or salt.
  • the compounds and compositions of this invention provide control of diseases caused by a broad spectrum of fungal plant pathogens in the Basidiomycete,
  • Ascomycete, Oomycete and Deuteromycete classes are effective in controlling a broad spectrum of plant diseases, particularly foliar pathogens of ornamental, vegetable, field, cereal, and fruit crops. These pathogens include Plasmopara viticola, Phytophthora infestans, Peronospora tabacina, Pseudoperonospora cubensis, Pythium aphanidermatum, Alternaria brassicae, Septoria nodorum, Cercosporidium personatum, Cercospora arachidicola, Pseudocercosporella herpotrichoides, Cercospora beticola, Botrytis cinerea, Monilinia fructicola, Pyricularia oryzae, Podosphaera
  • Compounds of this invention can also be mixed with one or more other insecticides, fungicides,
  • insecticides such as monocrotophos, carbofuran, tetrachlorvinphos,
  • esfenvalerate permethrin, profenofos, sulprofos, triflumuron, diflubenzuron, methoprene, buprofezin, thiodicarb, acephate, azinphosmethyl, chlorpyrifos, dimethoate, fipronil, flufenprox, fonophos, isofenphos, methidathion, methamidophos, phosmet, phosphamidon, phosalone, pirimicarb, phorate, terbufos, trichlorfon, methoxychlor, bifenthrin, biphenate, cyfluthrin, fenpropathrin, fluvalinate, flucythrinate,
  • fungicides such as carbendazim, thiuram, dodine, maneb, chloroneb, benomyl, cymoxanil, fenpropidine, fenpropimorph, triadimefon, captan, thiophanate-methyl, thiabendazole, phosethyl-Al, chlorothalonil, dichloran, metalaxyl, captafol, iprodione, oxadixyl, vinclozolin,
  • nematocides such as aldoxycarb, fenamiphos and
  • bactericides such as oxytetracyline, streptomycin and tribasic copper sulfate; acaricides such as binapacryl, oxythioquinox, chlorobenzilate, dicofol, dienochlor, cyhexatin, hexythiazox, amitraz, propargite, tebufenpyrad and fenbutatin oxide; and biological agents such as Bacillus thuringiensis and baculovirus.
  • Plant disease control is ordinarily accomplished by applying an effective amount of a compound of this invention either pre- or post-infection, to the plant or portion of the plant to be protected such as the roots, stems, foliage, fruit, seeds, tubers or bulbs, or to the media (soil or sand) in which the plants to be protected are growing.
  • the compounds can also be applied to the seed to protect the seed and seedling.
  • Rates of application for these compounds can be influenced by many factors of the environment and should be determined under actual use conditions.
  • Foliage can normally be protected when treated at a rate of from less than 1 g/ha to 5,000 g/ha of active ingredient. Seed and seedlings can normally be
  • Test compounds were first dissolved in acetone in an amount equal to 3% of the final volume and then suspended at a concentration of 200 ppm in purified water containing 250 ppm of the surfactant Trem ® 014
  • test suspensions were then used in the following tests.
  • test suspension was sprayed to the point of run-off on wheat seedlings. The following day the seedlings were inoculated with a spore dust of Erysiphe graminis f. sp. tritici, (the causal agent of wheat powdery mildew) and incubated in a growth chamber at
  • test suspension was sprayed to the point of run-off on wheat seedlings. The following day the seedlings were inoculated with a spore suspension of
  • Puccinia recondita (the causal agent of wheat leaf rust) and incubated in a saturated atmosphere at 20°C for 24 h, and then moved to a growth chamber at 20°C for 6 days, after which disease ratings were made.
  • test suspension was sprayed to the point of run-off on rice seedlings.
  • seedlings were inoculated with a spore suspension of Pyricularia oryzae (the causal agent of rice blast) and incubated in a saturated atmosphere at 27°C for 24 h, and then moved to a growth chamber at 30°C for 5 days, after which disease ratings were made.
  • test suspension was sprayed to the point of run-off on tomato seedlings.
  • seedlings were inoculated with a spore suspension of Phytophthora infestans (the causal agent of potato and tomato late blight) and incubated in a saturated atmosphere at 20°C for 24 h, and then moved to a growth chamber at 20°C for 5 days, after which disease ratings were made.
  • Phytophthora infestans the causal agent of potato and tomato late blight
  • test suspension was sprayed to the point of run-off on grape seedlings.
  • seedlings were inoculated with a spore suspension of Plasmopara viticola (the causal agent of grape downy mildew) and incubated in a saturated atmosphere at 20°C for 24 h, moved to a growth chamber at 20°C for 6 days, and then incubated in a saturated atmosphere at 20°C for 24 h, after which disease ratings were made.
  • Plasmopara viticola the causal agent of grape downy mildew
  • test suspension was sprayed to the point of run-off on cucumber seedlings.
  • seedlings were inoculated with a spore suspension of Botrytis cinerea (the causal agent of gray mold on many crops) and incubated in a saturated atmosphere at 20°C for 48 h, and moved to a growth chamber at 20°C for 5 days, after which disease ratings were made.
  • Botrytis cinerea the causal agent of gray mold on many crops
  • Results for Tests A-F are given in Table C.
  • a rating of 100 indicates 100% disease control and a rating of 0 indicates no disease control

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Substituted pyrido[1,2-a]pyrimidinone compounds of formula (I) wherein Q is O or S; W is O; S; S(O); S(O)2; NH; or NR9; X is CR3 or N; Y is CR4 or N; Z is CR?5=CR6; CR5¿=N; N=CR6; S; O; or NR?7; and R1, R2, R3, R4, R5, R6 and R7¿ are various groups; and agricultural compositions containing one or more such compounds useful as fungicides for control of diseases in plants are disclosed.

Description

TITLE
SUBSTITUTED PYRIDO ( 1 ,2-A) PYRIMIDINONE DERIVATIVES AS FUNGICIDES
This invention relates to certain substituted pyrido [1,2-a]pyrimidinone compounds useful as
fungicides, their agriculturally suitable salts and compositions, and methods of their use as general or selective fungicides, in particular for the control of wheat powdery mildew both preventive and curativeUrban et al., Helv. Chim . Acta, 1970, 53, 905, disclose pyrido [1,2-a]pyrimidinones of Formula i and their use as analgesics and antiinflammatory agents.
Figure imgf000003_0001
U.S. 3,755,582 issued August 28, 1973 and U.S. 3,867,384 issued February 18, 1975, each disclose 4 (3H)-quinazolinones of Formula ii and their use as agricultural fungicides.
Figure imgf000003_0002
wherein:
W is O; S or NH; and
Z is O or S. SUMMARY OF THE INVENTION
This invention comprises compounds of Formula I including all geometric and stereoisomers, N-oxides, agriculturally-suitable salts thereof, agricultural compositions containing them and method of use of said compounds, salts, or compositions as fungicides,
Figure imgf000004_0001
wherein:
Q is O or S;
W is O; S; S(O); S(O)2; NH; or NR9;
X is CR3 or N;
Y is CR4 or N;
Z is CR5=CR6; CR5=N; N=CR6; S; O; or NR7; having the directionality of the CR5=CR6, CR5=N and N=CR6 linkages such that the moiety depicted on the left side of the double bond is bonded to Y and the moiety on the right side of the double bond is bonded to the ring junction;
R1 is C1-C18 alkyl; C3-C7 cycloalkyl; C2-C18
alkenyl; C2-C18 alkynyl; C1-C18 haloalkyl; C2-C18 haloalkenyl; C2-C18 haloalkynyl; C2-C18 alkoxyalkyl; C2-C18 alkylthioalkyl; C2-C18 alkylsulfinylalkyl; C2-C18 alkylsulfonylalkyl;
C4-C18 cycloalkylalkyl; C4-C18 alkenyloxyalkyl; C4-C18 alkynyloxyalkyl; C4-C18 cycloalkyloxyalkyl; C4-C18 alkenylthioalkyl; C4-C18 alkynylthioalkyl; C6-C18 cycloalkylthioalkyl; C2-C18 haloalkoxyalkyl; C3-C18 haloalkenyloxyalkyl;
C4-C18 haloalkynyloxyalkyl; C4-C18 alkoxyalkenyl; C4-C18 alkoxyalkynyl; C4-C18 alkylthio alkenyl; C4-C18 alkylthioalkynyl; C4-C18 trialkylsilylalkyl; C1-C18 alkyl substituted with NR8R10, cyano, or nitro; C1-C8 alkyl substituted with CO2R8; C1-C18 alkoxy; C1-C18 haloalkoxy; C3-C18 alkynyloxy; C3-C18 alkenyloxy; C1-C18 alkylthio; C3-C18 alkenylthio; or C3-C18 alkynylthio;
R2 is C1-C18 alkyl; C3-C7 cycloalkyl; C3-C18
alkenyl; C3-C18 alkynyl; C1-C18 haloalkyl;
C3-C18 haloalkenyl; C3-C18 haloalkynyl; C2-C18 alkoxyalkyl; C2-C18 alkylthioalkyl; C2-C18 alkylsulfinylalkyl; C2-C18 alkylsulfonylalkyl; C4-C18 cycloalkylalkyl; C4-C18 alkenyloxyalkyl; C4-C18 alkynyloxyalkyl; C4-C18 cycloalkyloxyalkyl; C4-C18 alkenylthioalkyl; C4-C18 alkynylthioalkyl; C6-C18 cycloalkylthioalkyl; C2-C18 haloalkoxyalkyl; C3-C18 haloalkenyloxyalkyl; C4-C18 haloalkynyloxyalkyl; C4-C18 alkoxyalkenyl; C4-C18 alkoxyalkynyl; C4-C18 alkylthioalkenyl; C4-C18 alkylthioalkynyl; C4-C18 trialkylsilylalkyl; C1-C18 alkyl substituted with NR8R10; C2-C18 cyanoalkyl; C2-C18
nitroalkyl; C1-C8 alkyl substituted with CO2R8; or phenyl, benzyl, or phenethyl each optionally substituted on the phenyl ring with R13; or
R1 and R2 can be taken together along with the
C=C-W fragment to which they are attached to form a 5-7 membered ring in which the R1-R2 bridge is a saturated, all-carbon chain
optionally substituted with C1-C12 alkyl;
R3 and R5 are each independently hydrogen; halogen;
C1-C4 alkyl; C1-C4 haloalkyl; C1-C4 alkoxy; or C2-C4 haloalkoxy;
R4 and R6 are each independently hydrogen; halogen;
C1-C8 alkyl; C3-C8 cycloalkyl; C2-C8 alkenyl;
C2-C8 alkynyl; C1-C8 haloalkyl; C3-C8 halo- alkenyl; C3-C8 haloalkynyl; C1-C8 alkoxy; C1-C8 haloalkoxy; C3-C8 alkenyloxy; C3-C8 alkynyloxy; C1-C8 alkylthio; C3-C8 alkenylthio; C3-C8 alkynylthio; C1-C8 alkylsulfinyl; C1-C8 alkylsulfonyl; C2-C8 alkoxyalkyl; C2-C8 alkylthioalkyl; C2-C8 alkylsulfinylalkyl; C2-C8 alkylsulfonylalkyl; C4-C8 cycloalkylalkyl; C3-C8 trialkylsilyl; cyano; nitro; carbomethoxy;
carboethoxy; or NR11R12;
R7 is C1-C4 alkyl or C1-C4 haloalkyl;
R8 and R9 are each independently C1-C4 alkyl;
R10 and R11 are each independently H or C1-C4 alkyl; R12 is C1-C8 alkyl;
R8' and R10, or the groups R11 and R12, can be taken together to form -CH2CH2CH2CH2-, -CH2(CH2)3CH2-,
-CH2CH2OCH2CH2-, -CH2CH (Me) CH2CH (Me)CH2-, or -CH2CH (Me) OCH (Me) CH2-; and
R13 is halogen; C1-C4 alkyl, C1-C4 alkoxy, or C1-C4 haloalkyl;
provided that:
i) when Z is CR5=CR6, then at least one substituent selected from the group consisting of R3, R4, R5 and R6, is hydrogen; and
ii) the total number of carbons in R3, R4,
R5 and R6 is equal to or less than 16; iii) the total number of nitrogen atoms
incorporated into the bicyclic
framework is less than or equal to four;
iv) R3 and R4 are not both hydrogen; and v) X and Y are not both nitrogen.
Preferred for reasons of ease of synthesis or greater fungicidal activity are compounds of Formula I, denoted as Preferred 1, wherein: W is O; S; NH; or NR9;
X is CR3;
Y is CR4;
R1 is C1-C8 alkyl; C2-C8 alkenyl; C2-C8
alkynyl; C1-C8 haloalkyl; C2-C8
haloalkenyl; C2-C8 alkoxyalkyl; C2-C8 alkylthioalkyl; C4-C8 cycloalkylalkyl; C2-C8 cyanoalkyl; C1-C8 alkoxy; C1-C18 haloalkoxy; C3-C8 alkenyloxy; C3-C8 alkenylthio; or C4-C8 alkenyloxyalkyl;
R2 is C1-C8 alkyl; C2-C8 alkenyl; C2-C8
alkynyl; C1-C8 haloalkyl; C2-C8
haloalkenyl; C2-C8 alkoxyalkyl; C2-C8 alkylthioalkyl; C4-C8 cycloalkylalkyl; C2-C8 cyanoalkyl; C4-C8 alkenyloxyalkyl; or phenyl optionally substituted with R13; and
R4 and R6 are each independently hydrogen; halogen; C1-C8 alkyl; C3-C8 cycloalkyl; C1-C8 haloalkyl; C1-C8 alkoxy; C1-C8 haloalkoxy; C1-C8 alkylthio; C1-C8 alkylsulfonyl; C2-C8 alkoxyalkyl; C2-C8 alkylthioalkyl; C4-C8 cycloalkylalkyl; C3-C8 trialkylsilyl; or cyano.
More preferred are compounds denoted as Preferred 2, of the above Preferred 1, wherein:
Q is O;
W is O; S; NH; or NMe;
Z is CR5=CR6; CR5=N; S; or O;
R1 is C1-C8 alkyl; C2-C8 alkenyl; C2-C8
alkynyl; C1-C8 haloalkyl; C2-C8 halo- alkenyl; C1-C8 alkoxy; C2-C8 alkoxyalkyl; or C3-C8 alkenyloxy;
R2 is C1-C8 alkyl; C2-C8 alkenyl; C2-C8
alkynyl; C1-C8 haloalkyl; C2-C8 halo- alkenyl; C2-C8 alkoxyalkyl; or phenyl optionally substituted with R13; and R4 and R6 are each independently hydrogen; halogen; C1-C8 alkyl; C1-C8 haloalkyl; C1-C8 alkoxy; C1-C8 haloalkoxy; C3-C8 trialkylsilyl; or cyano.
Even more preferred are compounds denoted as
Preferred 3, of the above Preferred 2, wherein:
Z is CR5=CR6 or S;
R1 is C1-C8 alkyl; C2-C8 alkenyl; C2-C8
alkynyl; C1-C8 haloalkyl; or C2-C8 haloalkenyl;
R2 is C1-C8 alkyl; C2-C8 alkenyl; C2-C8
alkynyl; C1-C8 haloalkyl; C2-C8
haloalkenyl; or phenyl optionally
substituted with R13; and
R4 and R6 are each independently hydrogen; halogen; C1-C8 alkyl; C1-C8 haloalkyl; C1-C8 alkoxy; or C1-C8 haloalkoxy.
Specifically preferred are compounds of Preferred 3 wherein said compounds are:
7-bromo-3-(n-propyl)-2-(n-propyloxy)-4H- pyrido[1,2-a]pyrimidin-4-one;
7,9-dibromo-3-(n-propyl)-2-(n-propyloxy)-4H- pyrido[1,2-a]pyrimidin-4-one; or
7-iodo-3-(n-propyl)-2-(n-propyloxy)-4H- pyrido[1,2-a]pyrimidin-4-one.
DETAILED DESCRIPTION OF THE INVENTION
In the above recitations, the term "alkyl", used either alone or in compound words such as "alkylthio," "haloalkyl," or "alkylthioalkyl" denotes straight-chain or branched alkyl; e.g., methyl, ethyl, n-propyl, i-propyl, or the different butyl, pentyl, hexyl, etc. isomers.
"Cycloalkyl" denotes cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl. The term "cycloalkyl oxyalkyl" denotes the cycloalkyl groups linked through an oxygen atom to an alkyl chain. Examples include cyclopentyloxymethyl and cyclohexyloxybutyl. The term "cycloalkylthioalkyl" are the cycloalkyl groups linked through a sulfur atom to an alkyl chain; e.g., cyclopropylthiopentyl. "Cycloalkylalkyl" denotes a
cycloalkyl ring attached to a branched or straight-chain alkyl; e.g. cyclopropylmethyl and cyclohexylbutyl.
"Alkenyl" denotes straight chain or branched alkenes; e.g., 1-propenyl, 2-propenyl, 3-propenyl and the different butenyl , pentenyl, hexenyl, etc.
isomers. Alkenyl also denotes polyenes such as
1,3-hexadiene and 2,4,6-heptatriene.
"Alkynyl" denotes straight chain or branched alkynes; e.g., ethynyl, 1-propynyl, 3-propynyl and the different butynyl, pentynyl, hexynyl, etc. isomers. "Alkynyl" can also denote moieties comprised of
multiple triple bonds; e.g., 2,7-octadiyne and
2, 5, 8-decatriyne.
"Alkoxy" denotes methoxy, ethoxy, n-propyloxy, isopropyloxy and the different butoxy, pentoxy,
hexyloxy, etc. isomers. "Alkoxyalkenyl" and "alkoxyalkynyl" denoted groups in which the alkoxy group is bonded throught the oxygen atom to an alkenyl or alkynyl group, respectively. Examples include
CH3OCH2CH=CH and (CH3) 2CHOCH2C≡CCH2. The corresponding sulfur derivatives are denoted "alkylthioalkenyl and "alkylthioalkynyl." Examples of the former include CH3SCH2CH=CH and CH3CH2SCH2 (CH3) CH=CHCH2, and an example of the latter is CH3CH2CH2CH2SCH2C≡C.
"Alkenyloxy" denotes straight chain or branched alkenyloxy moieties. Examples of alkenyloxy include H2C=CHCH2O, (CH3)2C=CHCH2O, (CH3) CH=CHCH2O,
(CH3)CH=C(CH3)CH2O and CH2=CHCH2CH2O. "Alkenylthio" denotes the similar groups wherein the oxygen atom is replaced with a sulfur atom; e.g., H2C=CHCH2S and
(CH3)CH=C(CH3)CH2S. The term "alkenyloxyalkyl" denotes groups in which the alkenyloxy moiety is attached to an alkyl group. Examples include H2C=CHCH2OCH2CH2,
H2C=CHCH2OCH(CH3)CH2, etc. "Alkenylthioalkyl" denotes the alkenylthio moieties bonded to an alkyl group.
Examples include H2C=CHCH2SCH(CH3) CH(CH3) and
(CH3) CH=C (CH3) CH2SCH2.
"Alkynyloxy" denotes straight or branched
alkynyloxy moieties. Examples include HC≡CCH2O,
CH3C≡CCH2O and CH3C≡CCH2CH2O . "Alkynyloxyalkyl" denotes alkynyloxy moieties bonded to alkyl groups; e.g.,
CH3C≡CCH2OCH2CH2 and HC≡CCH2OCH (CH3) CH2.
"Alkynylthioalkyl" denotes alkynylthio moieties bonded to alkyl groups. Example include CH3C≡CCH2SCH2CH2 and CH3C≡CCH2CH2SCH(CH3)CH2.
"Alkylthio" denotes methylthio, ethylthio, and the different propylthio, butylthio, pentylthio and
hexylthio isomers. "Alkylthioalkyl" denotes alkylthio groups attached to an alkyl chain; e.g.,
CH3CH2SCH2CH(CH3) and (CH3) 2CHSCH2.
"Alkylsulfinyl" denotes both enantiomers of an alkylsulfinyl group. For example, CH3S(O), CH3CH2S(O), CH3CH2CH2S(O), (CH3)2CHS(O) and the different
butylsulfinyl, pentylsulfinyl and hexylsufinyl isomers. "Alkylsulfinylalkyl" denotes alkylsulfinyl groups attached to an alkyl chain; e.g., CH3CH2S(O)CH2CH(CH3) and (CH3)2CHS(O)CH2.
Examples of "alkylsulfonyl" include CH3S(O)2,
CH3CH2S(O)2, CH3CH2CH2S(O)2, (CH3)2CHS(O)2 and the different butylsulfonyl, pentylsulfonyl and hexylsulfonyl isomers. "Alkylsulfonylalkyl" denotes alkylsulfonyl groups attached to an alkyl chain; e.g.,
CH3CH2S(O)2CH2CH(CH3) and (CH3)2CHS(O)2CH2.
The term "halogen", either alone or in compound words such as "haloalkyl", denotes fluorine, chlorine, bromine or iodine. Further, when used in compound words such as "haloalkyl", said alkyl may be partially or fully substituted with halogen atoms which may be the same or different. Examples of "haloalkyl" include F3C, ClCH2, CF3CH2 and CF3CF2. Examples of
"haloalkenyl" include (Cl)2C=CHCH2 and CF3CH2CH=CHCH2. "Haloalkenyloxyalkyl" denotes haloalkenyl groups bonded to oxygen and in turn bonded to alkyl groups. Examples include CF3CH2CH=CHCH2OCH2 and (Cl) 2C=CHCH2OCH2CH2.
Examples of "haloalkynyl" include HC≡CCHCl, CF3C≡C,
CCl3C≡C and FCH2C≡CCH2. "Haloalkynyloxyalkyl" denotes haloalkynyl groups bonded through an oxygen atom to an alkyl moiety. Examples include CF3C≡CCH2OCH2CH2,
ClCH2C≡CCH2CH2OCH(CH3), etc. Examples of "haloalkoxy" include CF3O, CCl3CH2O, CF2HCH2CH2O and CF3CH2O.
"Haloalkoxyalkyl" denotes haloalkoxy groups bonded to straight-chain or branched alkyl groups; e.g.,
CF2HCH2CH2OCH2CH2, CCl3CH2OCH (CH3) and CF3OCH2.
"Trialkylsilyl" designates a group with three alkyl groups bonded to silicon; e.g., (CH3)3Si and
t-Bu(CH3)2Si. "Trialkylsilylalkyl" denotes
trialkylsilyl groups bonded to another straight-chain or branched alkyl group. Examples include (CH3)3SiCH2 and t-Bu(CH3)2SiCH2CH(CH3)CH2.
The total number of carbon atoms in a substituent group is indicated by the "Ci-Cj" prefix where i and j are numbers from 1 to 20. For example, C1-C3 alkyl-sulfonyl designates methylsulfonyl through propyl-sulfonyl; C2 alkoxyalkoxy designates CH3OCH2O; C3 alkoxyalkoxy designates, for example, CH3OCH2CH2O or
CH3CH2OCH2O; and C4 alkoxyalkoxy designates the various isomers of an alkoxy group substituted with a second alkoxy group containing a total of 4 carbon atoms, examples including CH3CH2CH2OCH2O, and CH3CH2OCH2CH2O. Examples of "alkoxyalkyl" include CH3OCH2, CH3OCH2CH2, CH3CH2OCH2, CH3CH2CH2CH2OCH2 and CH3CH2OCH2CH2. Compounds of Formula I can be prepared using one or more of the reactions and techniques described in
Schemes 1-4 hereinafter, or by following the procedures given in Examples 1-6. The variables W, X, Y, and Z and substituents R1-R13 in the compounds of Formulae
Ia-Ig and II-VII illustrated in Schemes 1-4 hereinafter are defined as for compounds of Formula I above.
The general method for preparing compounds of
Formula la is shown in Scheme 1. Based on a known synthetic method (A. E. Tschitschibabin, Chem. Ber. , 1924, 57, 168; G. R. Lappin, et. al., J. Org. Chem., 1950, 15, 377; A. R. Katritzky and A. J. Waring, J.
Chem. Soc. , 1962, 1544; J. Klosa, J. Prakt . Chem. , 1964, 26, 150; K. E. Schulte and J. Witt, Arch . Pharm., 1958, 252, 298), heating substituted aminoheterocycles of Formula II with substituted malonates of Formula III neat at 150-250°C or by heating in a high boiling solvent such as diethylbenzene (and allowing for the evaporation or distillation of ethanol formed in the reaction) gives zwitterionic intermediates of Formula IV. Substituted aminoheterocycles of Formula II and malonates of Formula III are known and in many cases are commercially available. Reaction of heterocycles of Formula IV with alkylating agents in the presence of base can give rise to alkylation on both oxygen and nitrogen (R. Urban, Helv. Chim. Acta, 1970, 53, 905). However, alkylation of heterocycles of Formula IV with reagents of Formula R2L wherein L is Cl, Br, I, OTs or OMs, in the presence of a mild base, such as potassium carbonate, in a polar aprotic solvent, such as
dimethylformamide, affords predominantly the desired O-alkylated product of Formula Ia with only a small amount of the more polar (by thin layer chromatography) N-alkylated mesoionic adduct of Formula V being
obtained. Products of Formulae Ia and V can be
separated by chromatography.
Figure imgf000013_0001
As illustrated in Scheme 2, heating intermediates of Formula IV in thionyl chloride or phosphorous oxychloride furnishes chloro-substituted heterocycles of Formula VI. Displacement of the chloro substituent, by reacting heterocycles of Formula VI with nucleophilic reagents of Formula R2GH (generally in the presence of base, e.g., sodium hydride or sodium methoxide, in a solvent such as tetrahydrofuran or dimethylformamide) gives products of Formula lb wherein G is O, S, NH, or NR9. Oxidation of compounds of
Formula lb wherein G is S with a suitable oxidizing agent such as meta-chloroperoxybenzoic acid furnishes products of Formula Ic.
Figure imgf000014_0001
Thiation of heterocycles of Formula Id with
phosphorous pentasulfide or Lawesson ' s reagent gives thiones of Formula Ie (Scheme 3) .
Figure imgf000014_0002
Compounds of Formula If can be made by the
procedure illustrated in Scheme 4. Intermediates of Formula Ig can be initially prepared by the methods shown in Schemes 1 and 2 whereby diethylmalonate is used as the malonate starting material (i.e., compounds of Formula III wherein R1 = H) in Scheme 1.
Bromination of compounds of Formula Ig with bromine or N-bromosuccinimide (NBS) yields brominated adducts of Formula VII which can be coupled with stannanes of Formula R14Sn (CH3) 3 in the presence of a palladium catalyst such as tetrakis(triphenylphosphine)-palladium(O) or bis(triphenylphosphine)palladium (II) chloride to afford products of Formula If.
Bromoheterocycles of Formula VII can also be coupled with terminal alkynes using palladium catalysis in the presence of base (such as triethylamine) and cuprous iodide.
Figure imgf000015_0001
Salts of compounds of Formula I can be formed by treating the free base of Formula I with strong acids such as hydrochloric or sulfuric acid. N-oxides of compounds of Formula I can be made by oxidizing
compounds of Formula I with a strong oxidizing agent such as meta-chloroperoxybenzoic acid.
INTERMEDIATE 1
Preparation of 7-Chloro-2-hydroxy-4-oxo-3-(2-propenyl)- pyrido[1,2-a]pyrimidin-1-ium Hydroxide, Inner Salt A mixture of 10.0 g (77.8 mmol) of 2-amino-5-chloropyridine and 23.0 g (115 mmol) of diethyl allyl-malonate in 60 mL of diethylbenzene was heated at reflux for 1 h with stirring. Ethanol generated during heating was removed by distillation. A solution initially formed followed by gradual precipitation of a yellow solid. On cooling, n-butyl chloride was added to enhance precipitation of this solid which was filtered, washed with n-butyl chloride, and dried. A 13.5 g yield of the title compound (m.p. 284-287°C) was obtained and used in subsequent steps without further purification.
EXAMPLE 1
Preparation of 7-Chloro-2-methoxy-3-(2-propenyl)-4H- pyrido[1,2-a]pyrimidin-4-one
To 2.0 g (8.5 mmol) of 7-chloro-2-hydroxy-4-oxo-3- (2-propenyl)-pyrido[1,2-a]pyrimidin-1-ium hydroxide, inner salt and 3.5 g (25.4 mmol) of potassium carbonate stirring in 50 mL of N,N-dimethylformamide, 2.6 mL of iodomethane was added and the mixture was stirred at room temperature for 18 h. Excess water and 200 mL of ethyl acetate were added. The organic layer was separated, washed with water (3 times) and brine, and dried over magnesium sulfate. The solvent was
evaporated in vacuo to give a dark oil which was flash chromatographed on silica gel (1:1 hexane/ethyl
acetate) to afford 0.7 g of the title compound, m.p. 139-141°C; 1H NMR (CDCl3) : δ 9.05 (d, 1H), 7.65, 7.60 (dd, 1H), 7,45 (d, 1H), 6.05-5.85 (m, 1H), 5.15-4.95 (m, 2H), 4.03 (s, 3H), 3.40 (d, 2H).
EXAMPLE 2
Preparation of 7-Chloro-3-(2-propenyl)-2-(2- propenyloxy)-4H-pyrido[1 ,2-a]pyrimidin-4-one
To 1.0 g (4.2 mmol) of 7-chloro-2-hydroxy-4-oxo-3-(2-propenyl)-pyrido[1,2-a]pyrimidin-1-ium hydroxide, inner salt and 1.5 g (10.8 mmol) of potassium carbonate stirring in 35 mL of N,N-dimethylformamide, 0.9 mL of allyl bromide was added and the mixture stirred at room temperature for 15 h. Excess water was added and the aqueous mixture was extracted with 125 mL of ethyl acetate. The organic layer was then washed with water (3 times) and brine and dried over magnesium sulfate. Evaporating in vacuo gave a solid residue which was flash chromatographed on silica gel (3:1 followed by 1:1 hexane/ethyl acetate) to afford 0.55 g of the title compound, m.p. 104-105°C; 1H NMR (CDCl3) : δ 9.07 (d, 1H), 7.63 (broad d, 1H), 7.42 (d, 1H), 6.10-5.90 (m, 2H), 5.42 (broad d, 1H), 5.25, 5.23 (dd, 1H), 5.13 (d, 1H), 5.05-4.95 (m, 3H), 3.42 (d, 2H).
INTERMEDIATE 2
Preparation of 7-Chloro-2-hydroxy-4-oxo-3-propyl- pyrido[1,2-a]pyrimidin-1-ium Hydroxide, Inner Salt A mixture of 11.5 g (89.4 mmol) of 2-amino-5-chloropyridine and 49.0 g (242 mmol) of diethyl propylmalonate was heated neat at 175°C for 3.5 h. Ethanol formed during heating was allowed to evaporate. A solution formed initially followed by gradual
precipitation of a yellow solid. After cooling, 25 mL of hexane were added and the solid was filtered, washed with hexane, and dried to yield 8.0 g of the title compound. This solid (m.p. 298-305°C) was used without further purification in the subsequent steps.
EXAMPLE 3
Preparation of 7-Chloro-2-methoxy-3-propyl- 4H-pyrido[1,2-a]pyrimidin-4-one
To 5.0 g (21.0 mmol) of 7-chloro-2-hydroxy-4-oxo-3-propyl-pyrido[1,2-a]pyrimidin-1-ium hydroxide, inner salt and 4.3 g (31.2 mmol) of potassium carbonate stirring in 35 ml of N,N-dimethylformamide, 4.5 g
(31.7 mmol) of iodomethane was added and the mixture was stirred at room temperature for 3 h. The reaction mixture was partitioned between 250 mL of water and 250 mL of ethyl acetate and the organic layer was separated followed by washing with water (3 times) and brine. After drying over magnesium sulfate, the solvent was removed in vacuo to give a yellow solid residue which was flash chromatographed on silica gel (5:1 followed by 3:1 hexane/ethyl acetate) to afford 2.8 g of the title compound, m.p. 135-137°C; 1H NMR (CDCl3) : δ 9.07 (d, 1H), 7.65, 7.60 (dd, 1H), 7.45 (d, 1H), 4.02 (s, 3H), 2.63 (t, 2H), 1.70-1.50 (m, 2H) , 0.97 (t, 3H).
EXAMPLE 4
Preparation of 7-Chloro-3-propyl-2-propyloxy- 4H-pyrido[1,2-a]pyrimidin-4-one
To 7.0 g (29 mmol) of 7-chloro-2-hydroxy-4-oxo-3-propyl-pyrido[1,2-a]pyrimidin-1-ium hydroxide, inner salt and 5.7 g (41 mmol) of potassium carbonate
stirring in 35 mL of N, N-dimethylformamide, 6.5 g
(38 mmol) of n-propyl iodide was added and the mixture stirred at room temperature for 14 h. The reaction mixture was partitioned between 150 mL of water and 200 mL of ethyl acetate and the organic layer separated followed by washing with water (3 times) and brine.
After drying over magnesium sulfate, the solvent was evaporated in vacuo to give a yellow solid residue which was flash chromatographed on silica gel
(10:1-5:1-3:1 hexane/ethyl acetate) to afford 5.2 g of the title compound as a white solid, m.p. 105-107°C; 1H NMR (CDCl3) : δ 9.04 (d, 1H), 7.60 (dd, 1H), 7.42 (d, 1H), 4.37 (t, 2H), 2.63 (t, 2H), 1.80 (q, 2H), 1.60 (q, 2H), 1.10-0.90 (m, 6H).
INTERMEDIATE 3
Preparation of 2,7-Dichloro-3-propyl-4H- pyrido[1,2-a]pyrimidin-4-one
A mixture of 10.0 g (42 mmol) of 7-chloro-2-hydroxy-4-oxo-3-propyl-pyrido[1,2-a]pyrimidin-1-ium hydroxide, inner salt stirring in 80 mL of phosphorous oxychloride was heated at reflux for 88 h. The dark reaction mixture was poured onto a large excess of ice. After extracting the resulting aqueous mixture with
800 mL of ethyl acetate, the organic layer was washed with water (2 times), saturated sodium bicarbonate and brine and dried over magnesium sulfate. Evaporating in vacuo gave dark oily/solid residue which was flashed chromatographed on silica gel (10:1-5:1-3:1
hexane/ethyl acetate) to give 1.8 g of the title compound, m.p. 169-171°C; 1H NMR (CDCl3) : δ 8.99 (d, 1H), 7.67 (dd, 1H), 7.55 (d, 1H), 2.80 (t, 2H), 1.65 (q, 2H), 1.02 (t, 3H).
EXAMPLE 5
Preparation of 7-Chloro-3-propyl-2-propylthio- 4H-pyrido[1,2-a]pyrimidin-4-one
To 0.5 g (2.0 mmol) of 2,7-dichloro-3-propyl-4H-pyrido[1,2-a]pyrimidin-4-one and 0.43 g (3.1 mmol) of potassium carbonate stirring in 30 mL of N,N-dimethyl-formamide at room temperature, 0.21 mL (2.3 mmol) of 1-propanethiol was added and the reaction was stirred at room temperature for 5 h. Water (75 mL) and ethyl acetate (125 mL) were added and the organic layer was separated and washed with water (3 times) and brine followed by drying over magnesium sulfate. Evaporation of solvent in vacuo provided an oily solid residue which was flash chromatographed on silica gel
(15:1-10:1 hexane/ethyl acetate) to yield 0.27 g of the title compound, m.p. 91-93°C; 1H NMR (CDCl3) : δ 9.0 (d, 1H), 7.55 (dd, 1H), 7.44 (d, 1H), 3.22 (t, 2H), 2.68
(t, 2H), 1.75 (q, 2H), 1.65 (q, 2H), 0.99-1.07 (m, 6H).
EXAMPLE 6
Preparation of 7-Chloro-3-propyl-2-propyloxy- 4H-pyrido[1,.2-a]pyrimidin-4-thione A mixture of 1.0 g (3.6 mmol) of 7-chloro-3-propyl-2-propyloxy-4H-pyrido[1,2-a]pyrimidin-4-one and 4.7 g (11 mmol) of phosphorous pentasulfide was heated at reflux for 32 h. An additional 3.0 g (6.8 mmol) of phosphorous pentasulfide was added and the mixture was heated at reflux for an additional 16 h. After
partitioning the reaction mixture between 150 mL of ethyl acetate and 10% aqueous hydrogen chloride, the organic layer was separated and washed with 10% aqueous hydrogen chloride (3 times with 100 mL), saturated sodium bicarbonate, and brine. The organic layer was dried over magnesium sulfate and evaporated in vacuo to give a solid residue. Flash column chromatography on silica gel (n-butyl chloride) afforded 0.16 g of the title compound, m.p. 117-120°C; 1H NMR (CDCl3) : δ 10.63 (d, 1H), 7.75 (dd, 1H), 7.57 (d, 1H), 4.43 (t, 2H), 3.07 (t, 2H), 1.84 (q, 2H), 1.68 (q, 2H),
0.95-1.15 (m, 6H).
Using the procedures outlined in Schemes 1-4, the compounds of Tables 1-7 can be prepared.
Figure imgf000020_0001
The following abbreviations are used in the tables which follow. t - is tertiary OMe - is methoxy
s - is secondary SEt - is ethylthio
n - is normal CN - is cyano
i - is iso TMS - is trimethylsilyl
Me - is methyl S(O)Me - is methylsulfinyl Et - is ethyl S(O)2Me - is methylsulfonyl Ph - is phenyl
TABLE 1
Compounds of Formula Ih
R3=R5=H; W=O
R4 R6 R1 R2
Cl H Me Me
Cl H Et n-propyl
Cl H n-propyl Me
Cl H 2-propenyl Me
Cl H 2-propenyl 2-propenyl
Cl H 2-propenyl n-propyl
Cl H n-propyl 2-propenyl
Br H 2-propenyl n-propyl
Br H 2-propenyl 2-propenyl
Br H 2-propenyl n-butyl
Br H Et n-propyl
Br H Et Et
Cl H Et 2-propenyl R4 R6 R1 R2
Cl H Me n-propyl
Cl H Me 2-propenyl
Cl H n-hexyl Me
Cl H n-butyl Et
Cl H i-propyl n-propyl
I H Me n-propyl
I H n-propyl i-propyl
I H 2-propenyl 2-propenyl
I H n-propyl Me
I H 2-propenyl n-propyl
I H Me n-heptyl
I H Et n-dodecyl
CF3 H Me Et
CF3 H n-propyl 2-propenyl
CF3 H 2-propenyl 2-propenyl
CF3 H 2-propenyl n-propyl
CF3 H 2-butenyl 2-propenyl
Cl H s-butyl Me
Cl Me i-pentyl 2-propenyl
Cl Me n-dodecyl n-hexyl
Br Me 2-propenyl 2-propenyl
Br Me n-propyl 2-propenyl
Me Me 2-propenyl 2-propenyl
Me Cl n-propyl Et
Me Br 2-butenyl 2-propenyl
Me Br n-propyl (CH2)17Me
Cl Cl 2-propenyl 2-propenyl
Cl Cl 2-pentenyl n-propyl
Cl Cl 2-hexenyl 2-butenyl
Br Br 2-propenyl 2-propenyl
Br Br n-propyl Me
I Me n-octyl n-heptyl
I H Me (CH2) 11Me
Me Me n-propyl s-butyl R4 R6 R1 R2
OCHF2 H 2-propenyl n-heptyl
OCH2CF3 H 2-propenyl n-octyl
OCF2CHF2 H 3-pentenyl 3-butynyl
OCH2CH2Cl H 5-hexynyl CH2OEt
OMe H 2-octenyl CH2CH2Cl
OEt Me CH2CH2F CH2CH2OMe
O-i-propyl H (CH2)3CF3 CH2CH2CH2F
O-s-pentyl H CHCl(CH2)14Me Me
O-n-octyl H CH2SMe 2-pentenyl
OCH2CH=CH2 H (CH2)7CH2F CH2SEt
SCH2C≡CH H CH2CH2CF3 CH2CH2Cl
Cl n-propyl 2-propynyl 2-butenyl t-butyl H (CH2)3OMe Et
i-pentyl H s-butyl 2-propenyl n-propyl H 2-butynyl n-decyl cyclopropyl H 3-butynyl (CH2)4OMe cyclopropylmethyl H CH2CH2OEt CH2CH2Cl cyclohexylmethyl H CH=CHMe Et
OCH2C(Me)3 H 4-pentenyl Me
S(O)2Et H (CH2)2CHMe2 n-propyl
CH2S (O) 2Me H 1-butenyl Me
Me OMe 2-heptenyl CH2CH=CH(CH2)8Me
Me OCHF2 2-dodecynyl C≡CCH2OMe
Me OCHMe2 C≡CCH2CH2OEt Me
Cl CH2OMe 6-hexenyl CH2CH2NMe2
Cl OCH2CH=CH2 CH2CH2NEt2 CH2CH=CMe2
TMS H CH2CH2CN Et
NO2 H n-propyl 2-propenyl
NMe2 H 2-propenyl n-butyl
C≡CCF3 H Et Et
CH=CHCF3 H Me n-hexyl
SCH2CH=CH2 Me Me Et
CH2C≡CEt H Et Me
Cl n-butyl Et CH2CH2TMS R4 R6 R1 R2
Me F Me CH2CH2SEt
F F Me cyclohexylmethyl
Br Et Et cyclooctyl
I H Me phenethyl
Cl H Et CH2CH2CN
Cl H Me CH2CH2NO2
Cl H 2-propenyl cyclopropylmethyl
Cl Cl Et benzyl
Br Me n-propyl phenyl
Cl H Et 4-chlorophenyl
Cl H n-propoxy n-butyl
CF3 H ethoxy 2-propenyl
Br H methoxy (CH2)17Me
Cl H n-propyl CH2CH=CHCl Cl H OCH2CH2Cl 2-butenyl
CF3 H CH2C(Cl)=CH2 n-butyl
Br Me CH2CH=CHCl CH2CH=CMe2 t-butyl H CH2CH=CMe2 OCH2CF3
CH=CHMe H Me cyclohexyl
C≡CMe H Me n-butyl
OCH2C≡CH H Et 2-cyclohexenyl
S(O)Me H Et CH2C≡CCF3
CH2S (O)Me H Me Et
CN H n-propyl 2-propenyl
CO2Me H Et n-propyl
CO2Et H Et 2-butenyl
Cl cyclohexyl Et Et
Cl CH=CHMe Et Et
Cl C≡CEt Me n-pentyl
Cl CH2Br Me 2-butynyl
Me CF3 2-propenyl 2-propenyl
Cl CH=CHCF3 n-butyl Me
Cl C≡CCF3 n-propyl n-propyl
Br OCH2C≡CH n-propyl CH2CH2Cl R4 R6 R1 R2
Cl SMe Me Et
Cl SCH2CH=CH2 Et 2-propynyl
Cl SCH2C≡CH Et 2-butynyl
Cl S(O)Me n-propyl Et
Cl S(O)2Me Et 2-hexenyl
Cl CH2SMe Et 2-propenyl
Cl CH2S(O)Me Me n-butyl
Cl CH2S(O)2Me Et CH2CH2F
Cl cyclopropylmethyl Et Et
Cl SiMe3 Me n-propyl
Me CN 2-propenyl Et
Me NO2 Me n-propyl
Me CO2Me Me Et
Me CO2Et n-propyl Me
Cl NMe2 Et Et
Cl H cyclopropyl 2-propenyl
Cl H C≡CCF3 Me
Br H CH2S(O)Me Et
Br H CH2S(O)2Me Me
Br H cyclopropylmethyl Me
Br H CH2OCH2C≡CH Me
Cl H CH2O[-CH2(CH2)3CH2-] Me
Cl H CH2SCH2CH=CH2 Me
Cl H CH2SCH2C≡CH Et
Cl H CH2S[-CH2(CH2)3CH2-] Me
Cl H CH2CH2OCHF2 n-propyl
Cl H CH2OCH2CF=CF2 Me
Cl H CH2OCH2C≡CCF3 Me
Cl H CH=CHCH2OCHF2 Et
Cl H CH2SCH2CH=CH2 Me
Cl H CH=CHCH2SMe Me
Cl H C≡CCH2SEt Me
Cl H CH2CH2SiMe3 Me
Cl H CH2CH2NMe2 Et R4 R6 R1 R2
Cl H CH2CH2NO2 n-propyl
Cl H CH2CH2CO2Me Et
Cl H O(CH2)3Me Me
Br H Et Et
Cl H SMe n-propyl
Cl H SCH2CH=CH2 Et
Cl H SCH2C≡CH 2-propenyl
Cl H Me CH2S(O)Me
Cl H Et CH2S(O)2Me
Cl H n-propyl CH2OCH2CH=CH2
Cl H n-propyl CH2OCH2C≡CH
Cl H Et CH2O[-CH2(CH2)3CH2-]
Cl H Me CH2SCH2CH=CH2
Cl H 2-propenyl CH2SCH2C≡CH
Cl H 2-propenyl CH2S[-CH2(CH2)3CH2-]
Cl H Me CH2CH2OCHF2
Cl H Et CH2OCH2CF=CF2
Cl H 2-butenyl CH2OCH2C≡CCF3
Cl H Me CH2CH=CHCH2SMe
Cl H 2-propenyl CH2C≡CCH2SEt
Cl H n-propyl CH2CH2NEt2
Cl H 2-propenyl CH2CH2CO2Et
Cl H CH2CH2N[-CH2(CH2)3CH2-] Me
Cl H Me CH2CH2N[-CH2(CH2)3CH2-]
Cl H Me 4-methylphenyl
Br H Et 3-methoxyphenyl
Cl Me n-propyl 3-CF3-Ph
Cl H 2-propenyl 4-bromophenyl
Cl H Me 4-bromophenethyl
I H Me 3-methylphenethyl
Cl H Et 2-chlorobenzyl R4 R6 R1 R2
Cl H Et 4-methylbenzyl Cl H Et 4-CF3-benzyl
Cl H Et 3-CF3-phenethyl Cl H Et 4-methoxybenzyl Cl H Me 4-methoxyphenethyl
R3=R5=H; W=S
R4 R6 R1 R2
CH2OEt Me CH=CHCF3 CH2CH=CHCl
CH2CH2OMe Cl n-propyl Et
cyclohexyl H n-butyl Me
SCH2CHMe2 Br 2-dodecenyl CH2CH2OEt
Cl H Me n-propyl
Cl H 2-propenyl 2-propenyl
CF3 H 2-propenyl n-propyl
Cl H Et 2-propenyl
Br H 2-butenyl n-propyl
Br Me n-propyl n-butyl
I H n-hexyl i-propyl
CF3 H Et i-butyl
CF3 H Me s-pentyl
CF3 H 2-propenyl Me
CF3 Me 2-hexenyl Et
Br Me 2-butynyl n-butyl
I H CH2CH2OMe 2-propenyl t-butyl H CH2SCHMe2 2-pentenyl
Et Me 1-butenyl phenyl
Cl Me Me 4-chlorophenyl
R3=R5=H
R4 R 6 W R1 R2
Cl H S (O) n-propyl n-propyl
Br H S (O) 2 n-pentyl Et
CF3 Me S (O) 2 i-propyl n-propyl R4 R6 W R1 R2
Cl H NH n-propyl n-butyl
Cl H NMe Et n-propyl
Cl H NH n-propyl phenyl
Br Me NMe n-butyl Me
I H n-butyl n-pentyl n-butyl
Br H NEt n-pentyl Et
Br H NH 2-propenyl phenyl
CF3 H NH 2-propenyl phenyl
Cl Cl NH n-propyl phenyl
I H NH n-butyl 2-chlorophenyl
Cl H NH Me n-hexyl
Br H NMe n-butyl n-heptyl
Br H NMe n-propyl benzyl
CF3 H NEt Et n-octyl
n-butyl H NH CH2CH2OMe phenyl
OCHF2 H NH CH2CH2F 2-heptenyl
Cl OEt NH CH2CH2CF=CF2 n-butyl TABLE 2
Compounds of Formula Ih
R3 R4 R5 R6 W R1 R2
H Cl Me H O n-propyl Me
H Cl Et H O n-propyl 2-propenyl
Cl H H H S 2-propenyl n-propyl
Me Br H H O Et Et
H Br OMe H O 2-butenyl n-propyl CF3 Br H H S n-butyl Et
H CF3 Me H O 2-propenyl 2-butenyl
Br H H H O 2-butynyl 2-pentenyl
Me Cl H H S 2-propenyl 2-propenyl
H I Me H O n-propyl 2-propenyl
H Br Me Me O n-heptyl CH2CH2OMe
H H OCHF2 Br S n-octyl CH2CH2OEt
Cl Me H Me O n-dodecyl CH2CH2Cl R3 R4 R5 R6 W R1 R2
H Cl Me Et O 2-decenyl CH2CH2CF3
H Cl Me OCHF2 O CH2OEt phenyl
Me OCHF2 H H O CH2CH2CN cyclopropylmet
F Me H Cl O s-pentyl 2-butynyl
H t-butyl F H O i-propyl n-propyl
OMe n-hexyl H H O 3-butenyl CH2CF3
H OCH2CF3 Et H O 5-hexynyl 3-butynyl CF3 NMe2 H H O OCH2CH=CH2 phenethyl
H OCH2CH2Cl Cl H O CH2CH2SMe 4-pentynyl
H SEt Et H O Me benzyl
H OEt OEt Me O CH2CH2F CH2CH2NMe2
OEt S(O)2CHMe2 H H O 2-hexyl CH2CH2NO2
H CH2OMe H H S CH2CH=CHCl n-propyl
Me CF3 H H S OCH2CH2Cl Me
H Cl Me Me O OCH2CF3 CH2CH=CHCl
H Cl Cl H NH n-propyl phenyl
OEt OCH2CHMe2 H H NMe n-butyl Me
H Br Br H NH 2-propenyl phenyl
H H Cl H NH CH2CH2OMe 4-chlorophenyl
H H Et H NEt n-hexyl n-butyl
H Cl H H NH Et benzyl
Me Me H H O i-pentyl Et
Br H H H O CH2OCH2CH=CH2 n-propyl
Cl H H F O CH2SCH2CH2Me Et
CF3 H H H S 2-butenyl Me
Me CF3 H H S Me phenyl
H Cl Et H O CH2C(Cl)=CH2 n-propyl
OCHF2 H H H O n-propyl 2-propenyl
H Me CF3 H O 2-propenyl n-propyl TABLE 3
Compounds of Formula Ii
R3 R4 R5 Q W R1 R2
H Cl H O O n-propyl Me
H Cl H O O n-propyl 2-propenyl
H Cl H O S 2-propenyl n-propyl
H Br H S O Et Et
H Br H O O 2-butenyl n-propyl
H Br H O S n-butyl Et
H CF3 H O O 2-propenyl 2-butenyl
H I H O O 2-butynyl 2-pentenyl
Me Cl H O S 2-propenyl 2-propenyl
H Cl Me O O n-propyl 2-propenyl
H Br Me O O n-heptyl CH2CH2OMe
H Me H O S n-octyl CH2CH2OEt
H Me H O O n-dodecyl CH2CH2Cl
H Cl H O O 2-decenyl CH2CH2CF3
H Cl H S O CH2OEt phenyl
H OCHF2 H O O CH2CH2CN cyclopropyi
F Me H O O s-pentyl 2-butynyl
H t-butyl H O O i-propyl n-propyl
H n-hexyl H O O 3-butenyl CH2CF3
H OCH2CF3 H O O 5-hexynyl 3-butynyl
H NMe2 H O O OCH2CH=CH2 phenethyl
H OCH2CH2Cl H O O CH2CH2SMe 4-pentynyl
H SEt H O O Me benzyl
H OEt H O O CH2CH2F CH2CH2NMe2
H S(O)2CHMe2 H O O 2-hexyl CH2CH2NO2
H CH2OMe H O S CH2CH=CHCl n-propyl
H CF3 H O S OCH2CH2Cl Me
H I H O O OCH2CF3 CH2CH=CHCl
H Cl H O NH n-propyl phenyl
H OCH2CHMe2 H O NMe n-butyl Me
H Br H O NH 2-propenyl phenyl R3 R4 R5 Q W R1 R2
H Br H O NH CH2CH2OMe 4-chlorophenyl
H Cl H S NEt n-hexyl n-butyl
H Cl H O NH Et benzyl
Me Me H O O i-pentyl Et
H I H O O CH2OCH2CH=CH2 n-propyl
H Cl H S O CH2SCH2CH2Me Et
H CF3 H O S 2-butenyl Me
H CF3 H O S Me phenyl
H Cl H O O CH2C(Cl)=CH2 n-propyl
H Me Cl O O n-propyl 2-pentenyl
TABLE 4
Compounds of Formula Ij
R3 R4 R6 Q W R1 R2
H Cl H O O n-propyl Me
H Cl H O O n-propyl 2-propenyl
H Cl H O S 2-propenyl n-propyl
H Br H S O Et Et
H Br Me O O 2-butenyl n-propyl
H Br H O S n-butyl Et
H CF3 H O O 2-propenyl 2-butenyl
H I H O O 2-butynyl 2-pentenyl
Me Cl H O S 2-propenyl 2-propenyl
H Cl Me O O n-propyl 2-propenyl
H Br Me O O n-heptyl CH2CH2OMe
H Me H O S n-octyl CH2CH2OEt
H Me Br O O n-dodecyl CH2CH2Cl
H Cl Cl O O 2-decenyl CH2CH2CF3
H Cl H S O CH2OEt phenyl
H OCHF2 H O O CH2CH2CN cyclopropylmethyl
F Me H O O s-pentyl 2-butynyl
H t-butyl H O O i-propyl n-propyl
H n-hexyl H O O 3-butenyl CH2CF3 R3 R4 R6 Q W R1 R2
H OCH2CF3 H O O 5-hexynyl 3-butynyl
H NMe2 H O O OCH2CH=CH2 phenethyl
H OCH2CH2Cl H O O CH2CH2SMe 4-pentynyl
H SEt H O O Me benzyl
H OEt H O O CH2CH2F CH2CH2NMe2
H S(O)2CHMe2 H O O 2-hexyl CH2CH2NO2
H CH2OMe H O S CH2CH=CHCl n-propyl
H CF3 H O S OCH2CH2Cl Me
H I H O O OCH2CF3 CH2CH=CHCl
H Cl Me O NH n-propyl phenyl
H OCH2CHMe2 H O NMe n-butyl Me
H Br H O NH 2-propenyl phenyl
H Br H O NH CH2CH2OMe 4-chlorophenyl
H Cl H S NEt n-hexyl n-butyl
H Cl H O NH Et benzyl
Me Me H O O i-pentyl Et
H I H O O CH2OCH2CH=CH2 n-propyl
H Cl H S O CH2SCH2CH2Me Et
H CF3 H O S 2-butenyl Me
H CF3 H O S Me phenyl
H Cl H O O CH2C(Cl)=CH2 n-propyl
H Me Cl O O n-propyl 2-pentenyl TABLE 5
Compounds of Formula Ik
R4 R5 R6 Q W R1 R2
Cl H H O O n-propyl Me
Cl H H O O n-propyl 2-propenyl
Cl H H O S 2-propenyl n-propyl
Br H H S O Et Et
Br H Me O O 2-butenyl n-propyl
Br H H O S n-butyl Et R4 R5 R6 Q W R1 R2
CF3 H H O O 2-propenyl 2-butenyl
I H H O O 2-butynyl 2-pentenyl
Cl Me H O A 2-propenyl 2-propenyl
Cl H Me O O n-propyl 2-propenyl
Br H Me O O n-heptyl CH2CH2OMe
Me Cl H O A n-octyl CH2CH2OEt
Me H Br O O n-dodecyl CH2CH2Cl
Cl H Cl O O 2-decenyl CH2CH2CF3
Cl H H S O CH2OEt phenyl
OCHF2 H H O O CH2CH2CN cyclopropylmethyl
Me F H O O s-pentyl 2-butynyl t-butyl H H O O i-propyl n-propyl n-hexyl H H O O 3-butenyl CH2CF3
OCH2CF3 H H O O 5-hexynyl 3-butynyl
NMe2 H H O O OCH2CH=CH2 phenethyl
OCH2CH2CH H H O O CH2CH2SMe 4-pentynyl
SEt H H O O Me benzyl
OEt H H O O CH2CH2F CH2CH2NMe2
S (O) 2CHMe2 H H O O 2-hexyl CH2CH2NO2
CH2OMe H H O A CH2CH=CHCl n-propyl
CF3 H H O A OCH2CH2Cl Me
I H H O O OCH2CF3 CH2CH=CHCl
Cl H Me O NH n-propyl phenyl
OCH2CHMe2 H H O NMe n-butyl Me
Br H H O NH 2-propenyl phenyl
Br H H O NH CH2CH2OMe 4-chlorophenyl
Cl H H A NEt n-hexyl n-butyl
Cl H H O NH Et benzyl
Me Me H O O i-pentyl Et
I H H O O CH2OCH2CH=CH2 n-propyl
Cl H H A O CH2SCH2CH2Me Et
CF3 H H O S 2-butenyl Me
CFo H H O S Me phenyl R4 R5 R6 Q W R1 R2
Cl H H O O CH2C(Cl)=CH2 n-propyl
Me H Cl O O n-propyl 2-pentenyl
TABLE 6
Compounds of Formula Il
R3 R6 R5 Q W R1 R2
H Cl H O O n-propyl Me
H Cl H O O n-propyl 2-propenyl
H Cl H O S 2-propenyl n-propyl
H Br H S O Et Et
H Br Me O O 2-butenyl n-propyl
H Br H O S n-butyl Et
H CF3 H O O 2-propenyl 2-butenyl
H I H O O 2-butynyl 2-pentenyl
Me Cl H O S 2-propenyl 2-propenyl
H Cl Me O O n-propyl 2-propenyl
H Br Me O O n-heptyl CH2CH2OMe
Cl Me H O S n-octyl CH2CH2OEt
H Me Br O O n-dodecyl CH2CH2Cl
H Cl Cl O O 2-decenyl CH2CH2CF3
H Cl H S O CH2OEt phenyl
H OCHF2 H O O CH2CH2CN cyclopropylmethyl
F Me H O O s-pentyl 2-butynyl
H t-butyl H O O i-propyl n-propyl
H n-hexyl H O O 3-butenyl CH2CF3
H OCH2CF3 H O O 5-hexynyl 3-butynyl
H NMe2 H O O OCH2CH=CH2 phenethyl
H OCH2CH2Cl H O O CH2CH2SMe 4-pentynyl
H SEt H O O Me benzyl
H OEt H O O CH2CH2F CH2CH2NMe2
H S(O)2CHMe2 H O O 2-hexyl CH2CH2NO2
H CH2OMe H O S CH2CH=CHCl n-propyl
H CF3 H O S OCH2CH2Cl Me
H I H O O OCH2CF3 CH2CH=CHCl R3 R6 R5 Q W R1 R2
H Cl Me O NH n-propyl phenyl
H OCH2CHMe2 H O NMe n-butyl Me
H Br H O NH 2-propenyl phenyl
H Br H O NH CH2CH2OMe 4-chlorophenyl H Cl H S NEt n-hexyl n-butyl H Cl H O NH Et benzyl
Me Me H O O i-pentyl Et
H I H O O CH2OCH2CH=CH2 n-propyl H Cl H S O CH2SCH2CH2Me Et
H CF3 H O S 2-butenyl Me
H CF3 H O S Me phenyl
H Cl H O O CH2C(Cl)=CH2 n-propyl H Me Cl O O n-propyl 2-pentenyl
TABLE 7
compounds of Formula I
X Y Z Q R1 R2
CH CCl S O O 2-propenyl n-propyl
CH CCl S O O 2-propenyl 2-propenyl
CH CCl S O O n-butyl n-hexyl
CH CCl S O O s-butyl 2-butenyl
CMe CCl S O O Et 2-pentenyl
CH CBr S O O n-propyl 2-propenyl
CH CCF3 S O O 2-propenyl n-propyl
CH CCF3 S O O 2-butenyl Et
CH CCF3 S O O Me n-propyl
CCF3 CH S O O CH2CH2OMe Et
CH CCF3 S O O CH2CH2Cl 2-hexenyl
CH CBr S O O 2-propenyl 2-propenyl
CH CBr S O O 2-butenyl n-propyl
CH CBr S O O CH=CHMe n-heptyl
CH CBr S O S n-butyl Et
CH CCF3 S S O 2-propenyl 2-butenyl
CMe CH S O O 2-butynyl 2-pentenyl X Y Z Q W R1 R2
CCl CMe S O S 2-propenyl 2-propenyl
CH CCl O O O n-propyl 2-propenyl
CH CCl O O O 2-propenyl n-propyl
CH CCl O O O 2-butenyl 2-propenyl
CH CCF3 O O O n-dodecyl Me
CH CBr O O O CH2C=CHCH2OMe n-butyl
CH CCF3 O O O CH2CH2CH2F Et
CMe CBr O O O n-heptyl CH2CH2OMe
CEt CCF3 O O S n-octyl CH2CH2OEt
CH CCl O O O n-dodecyl CH2CH2Cl
CH CCl O O O 2-decenyl CH2CH2CF3
CH CBr O O O CH2OMe CH2CF3
CH CCl O S O CH2OEt phenyl
CH CBr S O O CH2CH2CN cyclopropylmethyl
CH C-OCHF2 S O O CH2CH2OEt Me
CH C-t-butyl S O O n-propoxy s-butyl
CF C-Me S O O s-pentyl 2-butynyl
CH C-i-butyl S O O s-butyl n-propyl
CH C-n-hexyl S O O 3-butenyl CH2CF3
CH C-OCH2CF3 S O S 5-hexynyl 3-butynyl
CH C-NMe2 S O O OCH2CH=CH2 phenethyl
CH C-OCH2CH2Cl S O O CH2CH2SMe 4-pentynyl
CH C-SEt S O O Me benzyl
CH C-OEt S O O CH2CH2F CH2CH2NMe2
CH C-S(O)2CHMe2 S O O 2-hexyl CH2CH2NO2
CH CCH2OMe S O S CH2CH=CHCl n-propyl
CH CCF3 S O S OCH2CH2Cl Me
CH CCl O O O OCH2CF3 CH2CH=CHCl
CH CCl O O NH n-propyl phenyl
CH C-OCHMe2 O O NMe n-butyl Me
CH CBr S O NH 2-propenyl phenyl
CH CBr S O NH CH2CH2OMe 4-chlorophenyl X Y Z Q W R1 R2
CH CCl S S NEt n-hexyl n-butyl
CH CCl S O NH Et benzyl
CH CCl S O NH n-hexyl 4-chorophenyl
CH CBr S O NH 2-butenyl s-pentyl
CH CBr O O NEt CH2CH=CMe2 Et
CMe CMe S S O i-pentyl Et
CH CCl S S O CH2OCH2CH=CH2 n-propyl
CH CCl S S O CH2SCH2CH2Me Et
CH CCF3 S O S(O)2 2-butenyl Me
CH CCF3 S O S Me phenyl
CH CCl S O O CH2C(Cl)=CH2 n-propyl
CH CMe O S O n-propyl 2-pentenyl
CH CCF3 S O O n-propyl phenyl
CH CCl S O S(O)2 n-propyl n-propyl
CH CBr NMe O O n-butyl Et
CH CCl NMe O O Et Et
CH CCF3 NMe S O 2-propenyl n-propyl
CH CCl NCHF2 O O Me 2-butenyl
CH CCF3 NEt O O CH2SEt CH2CH2F
CCF3 CH NCH2CF3 O O Me Et
CH CBr n-propyl O O Me benzyl
CH CCl NCHF2 O O CH2OCH2CF3 2-hexenyl
CMe CMe S O O OCH2CH=CH2 CH2CH=CHCl
CH CCH2OMe S O O CH2CH2CN CH2CH2CH2F
CH C-t-butyl S O O CH2CF=CF2 Et
CH CEt S O O n-dodecyl n-octyl
CH C-i-propyl S O O CH=CHEt CH2CH2CF3
CH CBr O S O 1-butynyl CH2CH=CMe2
CH CCl O S O 3-butynyl CH2SEt
CH CCH2CF3 O S O methoxy s-pentyl
CH CMe S S O CH2OCH2CHMe2 4-chlorobenzyl
CH CCl S O O CH2C(Me)=CH2 Et X Y Z Q W R1 R2
CH CBr S O O Me 2-chlorophenyl
CH CBr S O O 1-hexynyl Et
CH CBr S O O n-propyl CH2CH2NMe2
CH CCl S O O CH=CHCF3 n-butyl
CH CBr S O O (CH2) 7CH2F Et
CH CCl S O O OCH2C≡CH n-propyl
CH CCF3 O O O 2-dodecenyl Me
CH CCl S O O Et CH2CH2TMS
CH CCl S O O Me phenethyl
Formulation/Utility
Compounds of this invention will generally be used in an agriculturally suitable composition. The
compositions of this invention comprise an effective amount of a compound of Formula I as defined above and at least one of (a) a surfactant, (b) an organic solvent, and (c) at least one solid or liquid diluent, useful formulations include dusts, granules, pellets, solutions, suspensions, emulsions, wettable powders, emulsifiable concentrates, dry flowables and the like, consistent with the physical properties of the active ingredient, mode of application and environmental factors such as soil type, moisture and temperature. Sprayable formulations can be extended in suitable media and used at spray volumes from about one to several hundred liters per hectare. High strength compositions are primarily used as intermediates for further formulation. The formulations will typically contain effective amounts of active ingredient, diluent and surfactant within the following approximate ranges which add up 100 weight percent. Weight Percent
Active
Ingredient Diluent Surfactant
Wettable Powders 25-90 0-74 1-10
Oil Suspensions, Emulsions, 5-50 40-95 0-15 Solutions, (including
Emulsifiable Concentrates)
Dusts 1-25 70-99 0-5
Granules, Baits and Pellets 0.01-99 5-99.99 0-15
High Strength Compositions 90-99 0-10 0-2
Typical solid diluents are described in Watkins, et al., Handbook of Insecticide Dust Diluents and
Carriers, 2nd Ed., Dorland Books, Caldwell, New Jersey. Typical liquid diluents and solvents are described in Marsden, Solvents Guide, 2nd Ed., Interscience, New York, 1950. McCutcheon 's Detergents and Emulsifiers Annual, Allured Publ. Corp., Ridgewood, New Jersey, as well as Sisely and Wood, Encyclopedia of Surface Active Agents, Chemical Publ. Co., Inc., New York, 1964, list surfactants and recommended uses. All formulations can contain minor amounts of additives to reduce foam, caking, corrosion, microbiological growth, etc.
Solutions are prepared by simply mixing the
ingredients. Fine solid compositions are made by blending and, usually, grinding as in a hammer mill or fluid energy mill. Water-dispersible granules can be produced be agglomerating a fine powder composition; see for example, Cross et al., Pesticide Formulations, Washington, D.C., 1988, pp 251-259. Suspensions are prepared by wet-milling; see, for example, U.S.
3,060,084. Granules and pellets can be made by
spraying the active material upon preformed granular carriers or by agglomeration techniques. See Browning, "Agglomeration", Chemical Engineering, December 4,
1967, pp 147-148, Perry 's Chemical Engineer 's Handbook, 4th Ed., McGraw-Hill, New York, 1963, pp 8-57 and following, and WO 91/13546. Pellets can be prepared as described in U.S. 4,172,714. Water-dispersible and water-soluble granules can be prepared as taught in DE 3,246,493.
For further information regarding the art of formulation, see U.S. 3,235,361, Col. 6, line 16 through Col. 7, line 19 and Examples 10 through 41;
U.S. 3,309,192, Col. 5, line 43 through Col. 7, line 62 and Examples 8, 12, 15, 39, 41, 52, 53, 58, 132,
138-140, 162-164, 166, 167 and 169-182; U.S.
2,891,855, Col. 3, line 66 through Col. 5, line 17 and Examples 1-4; Klingman, Weed Control as a Science, John Wiley and Sons, Inc., New York, 1961, pp 81-96; and Hance et al.. Weed Control Handbook, 8th Ed., Blackwell Scientific Publications, Oxford, 1989.
In the following Examples, all percentages are by weight and all formulations are worked up in
conventional ways. Compound numbers refer to compounds in Index Tables A and B, hereinafter.
Example A
Wettable Powder
Compound 3 65.0% dodecylphenol polyethylene glycol ether 2.0% sodium ligninsulfonate 4.0% sodium silicoaluminate 6.0% montmorillonite (calcined) 23.0%.
Example B
Granule
Compound 3 10.0% attapulgite granules (low volative
matter, 0.71/0.30 mm; U.S.S. No.
25-50 sieves) 90.0%.
Example C
Extruded Pellet
Compound 3 25.0% anhydrous sodium sulfate 10.0% crude calcium ligninsulfonate 5.0% sodium alkylnaphthalenesulfonate 1.0% calcium/magnesium bentonite 59.0%.
Example D
Emulsifiable Concentrate
Compound 3 20.0% blend of oil soluble sulfonates
and polyoxyethylene ethers 10.0% isophorone 70.0%. The compounds and compositions of this invention are useful as plant disease control agents. The present invention therefore further comprises a method for controlling plant diseases caused by fungal plant pathogens comprising applying to the plant or portion thereof to be protected, to the media in which the plant to be protected is growing, or to the plant seed or seedling an effective amount of a compound of
Formula I, an N-oxide thereof, an agriculturally suitable salt thereof, or a fungicidal composition containing said compound, N-oxide, or salt. The compounds and compositions of this invention provide control of diseases caused by a broad spectrum of fungal plant pathogens in the Basidiomycete,
Ascomycete, Oomycete and Deuteromycete classes. They are effective in controlling a broad spectrum of plant diseases, particularly foliar pathogens of ornamental, vegetable, field, cereal, and fruit crops. These pathogens include Plasmopara viticola, Phytophthora infestans, Peronospora tabacina, Pseudoperonospora cubensis, Pythium aphanidermatum, Alternaria brassicae, Septoria nodorum, Cercosporidium personatum, Cercospora arachidicola, Pseudocercosporella herpotrichoides, Cercospora beticola, Botrytis cinerea, Monilinia fructicola, Pyricularia oryzae, Podosphaera
leucotricha, Venturia inaequalis, Erysiphe graminis, Uncinula necatur, Puccinia recondita, Puccinia graminis, Hemileia vastatrix, Puccinia striiformis, Puccinia arachidis, Rhizoctonia solani, Sphaerotheca fuliginea, Fusarium oxysporum, Verticillium dahliae, Pythium aphanidermatum, Phytophthora megasperma and other generea and species closely related to these pathogens. They are particularly effective in the control of Erysiphe graminis, the causal agent of wheat powdery mildew, both preventive and curative.
Compounds of this invention can also be mixed with one or more other insecticides, fungicides,
nematocides, bactericides, acaricides, semiochemicals, repellants, attractants, pheromones, feeding stimulants or other biologically active compounds to form a multicomponent pesticide giving an even broader spectrum of agricultural protection. Examples of other
agricultural protectants with which compounds of this invention can be formulated are: insecticides such as monocrotophos, carbofuran, tetrachlorvinphos,
malathion, parathion-methyl, methomyl, chlordimeform, diazinon, deltamethrin, oxamyl, fenvalerate,
esfenvalerate, permethrin, profenofos, sulprofos, triflumuron, diflubenzuron, methoprene, buprofezin, thiodicarb, acephate, azinphosmethyl, chlorpyrifos, dimethoate, fipronil, flufenprox, fonophos, isofenphos, methidathion, methamidophos, phosmet, phosphamidon, phosalone, pirimicarb, phorate, terbufos, trichlorfon, methoxychlor, bifenthrin, biphenate, cyfluthrin, fenpropathrin, fluvalinate, flucythrinate,
tralomethrin, metaldehyde and rotenone; fungicides such as carbendazim, thiuram, dodine, maneb, chloroneb, benomyl, cymoxanil, fenpropidine, fenpropimorph, triadimefon, captan, thiophanate-methyl, thiabendazole, phosethyl-Al, chlorothalonil, dichloran, metalaxyl, captafol, iprodione, oxadixyl, vinclozolin,
kasugamycin, myclobutanil, tebuconazole, difenoconazole, diniconazole,- fluquinconazole, ipconazole, metconazole, penconazole, propiconazole, uniconzole, flutriafol, prochloraz, pyrifenox, fenarimol,
triadimenol, diclobutrazol, copper oxychloride, furalaxyl, folpet, flusilazol, blasticidin S,
diclomezine, edifenphos, isoprothiolane, iprobenfos, mepronil, neo-asozin, pencycuron, probenazole,
pyroquilon, tricyclazole, validamycin, and flutolanil; nematocides such as aldoxycarb, fenamiphos and
fosthietan; bactericides such as oxytetracyline, streptomycin and tribasic copper sulfate; acaricides such as binapacryl, oxythioquinox, chlorobenzilate, dicofol, dienochlor, cyhexatin, hexythiazox, amitraz, propargite, tebufenpyrad and fenbutatin oxide; and biological agents such as Bacillus thuringiensis and baculovirus.
In certain instances, combinations with other fungicides having a similiar spectrum of control but a different mode of action will be particularly
advantageous for resistance management.
Plant disease control is ordinarily accomplished by applying an effective amount of a compound of this invention either pre- or post-infection, to the plant or portion of the plant to be protected such as the roots, stems, foliage, fruit, seeds, tubers or bulbs, or to the media (soil or sand) in which the plants to be protected are growing. The compounds can also be applied to the seed to protect the seed and seedling.
Rates of application for these compounds can be influenced by many factors of the environment and should be determined under actual use conditions.
Foliage can normally be protected when treated at a rate of from less than 1 g/ha to 5,000 g/ha of active ingredient. Seed and seedlings can normally be
protected when seed is treated at a rate of from 0.1 to 10 g per kilogram of seed. The following Tests demonstrate the control
efficacy of compounds of this invention on specific pathogens. The pathogen control protection afforded by the compounds is not limited, however, to these
species. See Index Tables A and B for compound
descriptions.
Test compounds were first dissolved in acetone in an amount equal to 3% of the final volume and then suspended at a concentration of 200 ppm in purified water containing 250 ppm of the surfactant Trem® 014
(polyhydric alcohol esters). The resulting test suspensions were then used in the following tests.
TEST A
The test suspension was sprayed to the point of run-off on wheat seedlings. The following day the seedlings were inoculated with a spore dust of Erysiphe graminis f. sp. tritici, (the causal agent of wheat powdery mildew) and incubated in a growth chamber at
20°C for 7 days, after which disease ratings were made.
TEST B
The test suspension was sprayed to the point of run-off on wheat seedlings. The following day the seedlings were inoculated with a spore suspension of
Puccinia recondita (the causal agent of wheat leaf rust) and incubated in a saturated atmosphere at 20°C for 24 h, and then moved to a growth chamber at 20°C for 6 days, after which disease ratings were made.
TEST C
The test suspension was sprayed to the point of run-off on rice seedlings. The following day the seedlings were inoculated with a spore suspension of Pyricularia oryzae (the causal agent of rice blast) and incubated in a saturated atmosphere at 27°C for 24 h, and then moved to a growth chamber at 30°C for 5 days, after which disease ratings were made. TEST D
The test suspension was sprayed to the point of run-off on tomato seedlings. The following day the seedlings were inoculated with a spore suspension of Phytophthora infestans (the causal agent of potato and tomato late blight) and incubated in a saturated atmosphere at 20°C for 24 h, and then moved to a growth chamber at 20°C for 5 days, after which disease ratings were made.
TEST E
The test suspension was sprayed to the point of run-off on grape seedlings. The following day the seedlings were inoculated with a spore suspension of Plasmopara viticola (the causal agent of grape downy mildew) and incubated in a saturated atmosphere at 20°C for 24 h, moved to a growth chamber at 20°C for 6 days, and then incubated in a saturated atmosphere at 20°C for 24 h, after which disease ratings were made.
TEST F
The test suspension was sprayed to the point of run-off on cucumber seedlings. The following day the seedlings were inoculated with a spore suspension of Botrytis cinerea (the causal agent of gray mold on many crops) and incubated in a saturated atmosphere at 20°C for 48 h, and moved to a growth chamber at 20°C for 5 days, after which disease ratings were made.
Index Table A
Compounds of Formula Ih wherein:
Cpd m.p.
# R3 R4 R 5 R6 W R1 R2 °C
1 H Me H Br O allyl Me 149-150
2 H Cl H H O allyl Me 139-141
3 H Cl H H O allyl allyl 104-105
4 H Cl H H O allyl Et 111-113
5 H Cl H H O n-propyl Me 135-137 Cpd m.p.
# R3 R4 R5 R6 W R1 R2 ºC
6 H Cl H H O allyl i-propyl 105-107
7 H Cl H H O allyl n-propyl 107-109
8 H Cl H Cl O allyl Me 121-122
9 H Cl H H O allyl propargyl 125-126
10 H Cl H H O -CH2CH2CH2- 222-224
11 H H Me H O allyl Me 90-92
12 H Cl H H O Et Me 131-133
13 H Cl H H O Me Me 165-167
14 H Cl H H O n-butyl Me 101-102
15 H Me H Br O allyl allyl 108-110
16 H Cl H H O allyl n-hexyl 94-95
17 H H H Me O allyl Me 106-107
18 H Cl H H O n-propyl n-propyl 105-107
19 H Cl H H O CH2CH2CN n-propyl 137-138 20 H Cl H H O n-propyl allyl 101-103
21 H Cl H H O 2-butenyl allyl 130-132 22 H Cl H H O 2-butenyl Me 155-157
23 H Cl H Cl O allyl allyl 101-103 24 H Cl H Cl O allyl n-propyl 79-81 25 H Cl H H O allyl CH2C(C1)=CH2 130-131 26 H Cl H H O allyl 2-butenyl 105-107 27 H Br H H O allyl Me 143-144 28 H Cl H H O n-butyl allyl 115-117 29 H Cl H H O allyl CH2CH=CHCl 120-125
30 H Br H H O allyl allyl 113-115 31 H Cl H H O Et allyl 112-114 32 H CF3 H H O allyl Me 140-142
33 H Cl H H O n-propyl Ph 159-162 34 H Cl H H O allyl Me 91-93
35 H Br H Me O n-propyl n-propyl 142-144 36 H Br H H O n-propyl n-propyl 114-116 37 H Cl H H O n-butyl n-propyl 111-113 38 H Br H H O allyl n-propyl 124-125 Cpd m.p.
# R3 R4 R5 R6 W R1 R2 °C
39 H CF3 H H O allyl n-propyl 89-92
40 H CF3 H H O n-propyl n-propyl 80-81
41 H Cl H H O i-propyl Me 146-148
42 H Cl H H S n-propyl n-propyl 91-93
43 H Me H Br O n-propyl n-propyl 101-104
44 H Cl H H O i-propyl n-propyl 92-94
45 H Cl H H O n-propyl 2-butenyl 95-97
46 H Cl H H O n-propyl CH2CH=CMe2 95-97
47 H Cl H H O n-propyl CH2CF3 112-115
48 H Cl H H O n-propyl n-butyl 92-94
49 H Cl H H O n-propyl CHF2 103-105
50 H Cl H H O n-propyl phenethyl 96-98
51 H H H Me O n-propyl n-propyl 69-71
52 H Cl H H O n-propyl n-hexyl 92-94
53 H Cl H H O n-propyl i-butyl 122-124
54 H NO2 H H O n-propyl n-propyl 100-102
55 H NO2 H H O allyl allyl 94-96
56 H Me H H O n-propyl n-propyl 72-74 57 H Cl H H NH n-propyl n-propyl 101-103
58 H Cl H H O n-propyl n-heptyl 90-92 59 H Cl H H O n-propyl FCH2CH2CH2 109-110
60 H Cl H Cl O n-propyl n-propyl 97-99
61 H I H I O n-propyl n-propyl 192-194
62 H Br H H O n-hexyl n-propyl 88-90
63 H Cl H H O n-hexyl Me 103-109 64 H Cl H H O n-hexyl n-propyl 94-96 65 H Cl H H O n-propyl Et 110-112
66 H Br H Br O n-propyl n-propyl 131-133 67 H I H H O n-propyl n-propyl 121-124 68 H Cl H H O n-propyl CH2CH2OMe 95-96 69 H MeS H H S n-propyl Me 111-113 70 H Cl H H S n-propyl Me 125-127 Cpd m.p.
# R3 R4 R5 R6 W R1 R2 °C
71 H Cl H H NMe n-propyl Me 85-88
72 H Cl H H O OMe n-propyl 120-122
73 H Cl H H O OMe Me 168-170
74 Br H H H O n-propyl n-propyl 56-59
75 H Cl H Br O n-propyl n-propyl 110-112
76 H H H I O n-propyl n-propyl 82-85
Figure imgf000048_0001
Results for Tests A-F are given in Table C. In the table, a rating of 100 indicates 100% disease control and a rating of 0 indicates no disease control
(relative to the controls). NT = Not Tested.
TABLE C
Cmpd Test Test Test Test Test Test
No. A B C D E F
1 100 79 7 0 21* 40*
2 99 0 28* 0 0 0
3 100 17 0 0 18 38
4 98 0 0 16 18 0
5 100 0 0 0 0 38*
6 96 12 71 74 84 7
7 100 12 23 18* 13* 0
8 100 63 0 0 22* 0
9 97 0 0 25 0 0
10 34* 0 0 0 25 0
11 77 18 0 24 22 0
12 81 14 0 0 75 0
13 93 14 0 0 62 41
14 99 62 0 22 44 0
15 99 14 0 0 97 0
16 100 0 0 0 22 41
17 98 14 0 0 22 0
18 100 0 0 0 22 0
19 49 0 0 0 0 0
20 100 5 1 0 74 0
21 99 5 1 15 19 0
22 94 5 1 15 42 0
23 100 5 1 15 19 0
24 100 5* 1 40* 74 0
25 100* 16* 0* 0* 9* 0*
26 100 16* 0 22 56 0
27 100 0 0 22* 9 70*
28 100 0 0 0 71 0
29 100 0 0 22 9 0
30 100 62 0 0 35 47
31 100 16 0 22 100 0
32 74 16 0 22 9 0 Cmpd Test Test Test Test Test Test
No. A B C D E F
33 87 0 0 0 0 41
34 100 1 0 43 25* 0
35 100 1 0 0 25 10
36 100 1 0 0 25* 10
37 100 1 1 1 25 98*
38 100 1 0 0 46 0
39 100 1 0 0 0 0
40 100 1 0 0 0 0
41 97 1 0 0 0 0
42 98 1 0 20 25 0
43 100* 40* 0* 0* 13* 0*
44 99* 0* 0* 0* 13* 0*
45 100* 0* 0* 0* 38* 0*
46 100* 0* 0* 0* 13* 0*
47 98* 4* 0* 24* 14* 9*
48 100* 0* 0* 0* 13* 0*
49 16* 40* 0* 0* 38* 0*
50 0* 40 0 0 0 0
51 99* 40* 0* 0* 38* 0*
52 100* 40 0 0 0 0
53 99* 40 0 0 13 0
54 96 57 0* 18* 12* 0
55 69 3 0* 0* 0* 0*
56 98* 39* 0* 0* 12* 0*
57 97* 39* 0* 0* 12* 0*
58 89* 52* 0* 0* 43* 0*
59 100* 0* 0* 0* 43* 0*
60 100* 0* 0* 0* 43* 46*
61 100* 81* 0* 24* 0* 0*
62 84* 0* 0* 0* 17* 0*
63 84* 0* 0* 14* 17* 0*
64 57* 0* 0* 0* 18* 4*
65 NT 0* 0* 7* 0 4* Cmpd Test Test Test Test Test Test
No. A B C D E F
66 NT 0* 0* 0* 42* 4*
67 100* 0* 0* 0* 0* 4*
68 98* 0* 0* 20* 59* 0*
69 60* 0* 0* 0* 0* 0*
70 91* 0* 0* 0* 36* 0*
71 76* 0* 0* 0* 58* 31*
72 55* 19* 0* 61* 0* 0*
73 0* 64* 0* 0* 0* 0*
74 100* 41* 0* 0* 11* 81*
75 100* 0 0* 0* 13* 0*
*The compound was spray at a concentration of 40 ppm.

Claims

What is claimed is:
1. A compound of Formula I
Figure imgf000052_0001
wherein:
Q is O or S;
W is O; S; S (O) ; S(O)2; NH; or NR9;
X is CR3 or N;
Y is CR4 or N;
Z is CR5=CR6; CR5=N; N=CR6; S; O; or NR7; having the directionality of the CR5=CR6, CR5=N and N=CR6 linkages such that the moiety depicted on the left side of the double bond is bonded to Y and the moiety on the right side of the double bond is bonded to the ring junction;
R1 is C1-C18 alkyl; C3-C7 cycloalkyl; C2-C18
alkenyl; C2-C18 alkynyl; C1-C18 haloalkyl;
C2-C18 haloalkenyl; C2-C18 haloalkynyl; C2-C18 alkoxyalkyl; C2-C18 alkylthioalkyl; C2-C18 alkylsulfinylalkyl; C2-C18 alkylsulfonylalkyl; C4-C18 cycloalkylalkyl; C4-C18 alkenyloxyalkyl; C1-C18 alkynyloxyalkyl; C4-C18 cycloalkyloxyalkyl; C4-C18 alkenylthioalkyl; C4-C18 alkynylthioalkyl; C6-C18 cycloalkylthioalkyl; C2-C18 haloalkoxyalkyl; C3-C18 haloalkenyloxyalkyl; C4-C18 haloalkynyloxyalkyl; C4-C18 alkoxyalkenyl; C4-C18 alkoxyalkynyl; C4-C18 alkylthioalkenyl; C4-C18 alkylthioalkynyl; C4-C18 trialkylsilylalkyl; C1-C18 alkyl substituted with NR8R10, cyano, or nitro; C1-C8 alkyl substituted with CO2R8; C1-C18 alkoxy; C1-C18 haloalkoxy; C3-C18 alkynyloxy; C3-C18 alkenyloxy; C1-C18 alkylthio; C3-C18 alkenylthio; or C3-C18 alkynylthio;
R2 is C1-C18 alkyl; C3-C7 cycloalkyl; C3-C18
alkenyl; C3-C18 alkynyl; C1-C18 haloalkyl;
C3-C18 haloalkenyl; C3-C18 haloalkynyl; C2-C18 alkoxyalkyl; C2-C18 alkylthioalkyl; C2-C18 alkylsulfinylalkyl; C2-C18 alkylsulfonylalkyl;
C4-C18 cycloalkylalkyl; C4-C18 alkenyloxyalkyl; C4-C18 alkynyloxyalkyl; C4-C18 cycloalkyloxyalkyl; C4-C18 alkenylthioalkyl; C4-C18 alkynylthioalkyl; C6-C18 cycloalkylthioalkyl; C2-C18 haloalkoxyalkyl; C3-C18 haloalkenyloxyalkyl;
C4-C18 haloalkynyloxyalkyl; C4-C18 alkoxyalkenyl; C4-C18 alkoxyalkynyl; C4-C18 alkylthioalkenyl; C4-C18 alkylthioalkynyl; C4-C18 trialkylsilylalkyl; C1-C18 alkyl substituted with NR8R10; C2-C18 cyanoalkyl; C2-C18
nitroalkyl; C1-C8 alkyl substituted with CO2R8; or phenyl, benzyl, or phenethyl each optionally substituted on the phenyl ring with R13; or R1 and R2 can be taken together along with the
C=C-W fragment to which they are attached to form a 5-7 membered ring in which the R1-R2 bridge is a saturated, all-carbon chain
optionally substituted with C1-C12 alkyl;
R3 and R5 are each independently hydrogen; halogen;
C1-C4 alkyl; C1-C4 haloalkyl; C1-C4 alkoxy; or
C1-C4 haloalkoxy;
R4 and R6 are each independently hydrogen; halogen;
C1-C8 alkyl; C3-C8 cycloalkyl; C2-C8 alkenyl; C2-C8 alkynyl; C1-C8 haloalkyl; C3-C8
haloalkenyl; C3-C8 haloalkynyl; C1-C8 alkoxy;
C1-C8 haloalkoxy; C3-C8 alkenyloxy; C3-C8 alkynyloxy; C1-C8 alkylthio; C3-C8 alkenylthio; C3-C8 alkynylthio; C1-C8 alkylsulfinyl; C1-C8 alkylsulfonyl; C2-C8 alkoxyalkyl; C2-C8
alkylthioalkyl; C2-C8 alkylsulfinylalkyl; C2-C8 alkylsulfonylalkyl; C4-C8 cycloalkylalkyl;
C3-C8 trialkylsilyl; cyano; nitro; CO2Me;
CO2Et; or NR11R12;
R7 is C1-C4 alkyl or C1-C4 haloalkyl;
R8 and R9 are each independently C1-C4 alkyl;
R10 and R11 are each independently H or C1-C4 alkyl; R12 is C1-C8 alkyl;
R8 and R10, or the groups R11 and R12, can be taken together to form -CH2CH2CH2CH2-, -CH2(CH2)3CH2-, -CH2CH2OCH2CH2-, -CH2CH(Me)CH2CH(Me)CH2-, or -CH2CH(Me)OCH(Me)CH2-; and
R13 is halogen; C1-C4 alkyl, C1-C4 alkoxy, or C1-C4 haloalkyl;
provided that:
i) when Z is CR5=CR6, then at least one substituent selected from the group consisting of R3, R4, R5 and R6, is hydrogen; and
ii) the total number of carbons in R3, R4, R5 and R6 is equal to or less than 16; iϋ) the total number of nitrogen atoms
incorporated into the bicyclic
framework is less than or equal to four;
iv) R3 and R4 are not both hydrogen; and v) X and Y are not both nitrogen.
N-oxides and agriculturally suitable salts thereof.
2. A compound of Claim 1 wherein:
W is O; S; ΝH; or ΝR9;
X is CR3;
Y is CR4; R1 is C1-C8 alkyl; C2-C8 alkenyl; C2-C8 alkynyl; C1-C8 haloalkyl; C2-C8 haloalkenyl; C2-C8 alkoxyalkyl; C2-C8 alkylthioalkyl; C4-C8 cycloalkylalkyl; C2-C8 cyanoalkyl; C1-C8 alkoxy; C1-C18 haloalkoxy; C3-C8 alkenyloxy; C3-C8 alkenylthio; or C4-C8 alkenyloxyalkyl; R2 is C1-C8 alkyl; C2-C8 alkenyl; C2-C8
alkynyl; C1-C8 haloalkyl; C2-C8 haloalkenyl; C2-C8 alkoxyalkyl; C2-C8 alkylthioalkyl; C4-C8 cycloalkylalkyl; C2-C8 cyanoalkyl; C4-C8 alkenyloxyalkyl; or phenyl optionally substituted with R13; and
R4 and R6 are each independently hydrogen; halogen; C1-C8 alkyl; C3-C8 cycloalkyl; C1-C8 haloalkyl; C1-C8 alkoxy; C1-C8 haloalkoxy; C1-C8 alkylthio; C1-C8 alkylsulfonyl; C2-C8 alkoxyalkyl; C2-C8 alkylthioalkyl; C4-C8 cycloalkylalkyl;
C3-C8 trialkylsilyl; or cyano.
3. A compound of Claim 2 wherein:
Q is O;
W is O; S; NH; or NMe;
Z is CR5=CR6; CR5=N; S; or O;
R1 is C1-C8 alkyl; C2-C8 alkenyl; C2-C8
alkynyl; C1-C8 haloalkyl; C2-C8 haloalkenyl; C1-C8 alkoxy; C2-C8 alkoxyalkyl; or C3-C8 alkenyloxy;
R2 is C1-C8 alkyl; C2-C8 alkenyl; C2-C8
alkynyl; C1-C8 haloalkyl; C2-C8 haloalkenyl; C2-C8 alkoxyalkyl; or phenyl optionally substituted with R13; and R4 and R6 are each independently hydrogen; halogen; C1-C8 alkyl; C1-C8 haloalkyl; C1-C8 alkoxy; C1-C8 haloalkoxy; C3-C8 trialkylsilyl; or cyano.
4. A compound of Claim 3 wherein:
Z is CR5=CR6 or S;
R1 is C1-C8 alkyl; C2-C8 alkenyl; C2-C8
alkynyl; C1-C8 haloalkyl; or C2-C8 haloalkenyl;
R2 is C1-C8 alkyl; C2-C8 alkenyl; C2-C8
alkynyl; C1-C8 haloalkyl; C2-C8
haloalkenyl; or phenyl optionally
substituted with R13; and
R4 and R6 are each independently hydrogen; halogen; C1-C8 alkyl; C1-C8 haloalkyl; C1-C8 alkoxy; or C1-C8 haloalkoxy.
5. A compound of Claim 4 which is
7-bromo-3-(n-propyl)-1-(n-propyloxy)-4H- pyrido[1,2-a]pyrimidin-4-one;
7,9-dibromo-3-(n-propyl)-2-(n-propyloxy)-4H- pyrido[1,2-a]pyrimidin-4-one; or
7-iodo-3-(n-propyl)-2-(n-propyloxy)-4H- pyrido[1,2-a]pyrimidin-4-one.
6. A fungicidal composition comprising an effective amount of a compound of Formula I
Figure imgf000056_0001
wherein:
Q is O or S;
W is O; S; S (O); S(O)2; NH; or NR9;
X is CR3 or N;
Y is CR4 or N; Z is CR5=CR6; CR5=N; N=CR6; S; O; or NR7; having the directionality of the CR5=CR6, CR5=N and N=CR6 linkages such that the moiety depicted on the left side of the double bond is bonded to Y and the moiety on the right side of the double bond is bonded to the ring junction;
R1 is C1-C18 alkyl; C3-C7 cycloalkyl; C2-C18
alkenyl; C2-C18 alkynyl; C1-C18 haloalkyl;
C2-C18 haloalkenyl; C2-C18 haloalkynyl; C2-C18 alkoxyalkyl; C2-C18 alkylthioalkyl; C2-C18 alkylsulfinylalkyl; C2-C18 alkylsulfonylalkyl; C4-C18 cycloalkylalkyl; C4-C18 alkenyloxyalkyl; C4-C18 alkynyloxyalkyl; C4-C18 cycloalkyloxyalkyl; C4-C18 alkenylthioalkyl; C4-C18
alkynylthioalkyl; C6-C18 cycloalkylthioalkyl;
C2-C18 haloalkoxyalkyl; C3-C18 haloalkenyloxyalkyl; C4-C18 haloalkynyloxyalkyl; C4-C18 alkoxyalkenyl; C4-C18 alkoxyalkynyl; C4-C18 alkylthioalkenyl; C4-C18 alkylthioalkynyl;
C4-C18 trialkylsilylalkyl; C1-C18 alkyl
substituted with NR8R10, cyano, or nitro; C1-C8 alkyl substituted with CO2R8; C1-C18 alkoxy;
C1-C18 haloalkoxy; C3-C18 alkynyloxy; C3-C18 alkenyloxy; C1-C18 alkylthio; C3-C18 alkenylthio; or C3-C18 alkynylthio;
R2 is C1-C18 alkyl; C3-C7 cycloalkyl; C3-C18
alkenyl; C3-C18 alkynyl; C1-C18 haloalkyl;
C3-C18 haloalkenyl; C3-C18 haloalkynyl; C2-C18 alkoxyalkyl; C2-C18 alkylthioalkyl; C2-C18 alkylsulfinylalkyl; C2-C18 alkylsulfonylalkyl;
C4-C18 cycloalkylalkyl; C4-C18 alkenyloxyalkyl; C4-C18 alkynyloxyalkyl; C4-C18 cycloalkyloxyalkyl; C4-C18 alkenylthioalkyl; C4-C18 alkynylthioalkyl; C6-C18 cycloalkylthioalkyl; C2-C18 haloalkoxyalkyl; C3-C18 haloalkenyloxyalkyl;
C4-C18 haloalkynyloxyalkyl; C4-C18 alkoxy alkenyl; C4-C18 alkoxyalkynyl; C4-C18 alkylthioalkenyl; C4-C18 alkylthioalkynyl; C4-C18 trialkylsilylalkyl; C1-C18 alkyl substituted with NR8R10; C2-C18 cyanoalkyl; C2-C18 nitro- alkyl; C1-C8 alkyl substituted with CO2R8; or phenyl, benzyl, or phenethyl each optionally substituted on the phenyl ring with R13; or R1 and R2 can be taken together along with the
C=C-W fragment to which they are attached to form a 5-7 membered ring in which the R1-R2 bridge is a saturated, all-carbon chain
optionally substituted with C1-C12 alkyl;
R3 and R5 are each independently hydrogen; halogen;
C1-C4 alkyl; C1-C4 haloalkyl; C1-C4 alkoxy; or C1-C4 haloalkoxy;
R4 and R6 are each independently hydrogen; halogen;
C1-C8 alkyl; C3-C8 cycloalkyl; C2-C8 alkenyl; C2-C8 alkynyl; C1-C8 haloalkyl; C3-C8 haloalkenyl; C3-C8 haloalkynyl; C1-C8 alkoxy; C1-C8 haloalkoxy; C3-C8 alkenyloxy; C3-C8 alkynyloxy;
C1-C8 alkylthio; C3-C8 alkenylthio; C3-C8 alkynylthio; C1-C8 alkylsulfinyl; C1-C8 alkylsulfonyl; C2-C8 alkoxyalkyl; C2-C8 alkylthioalkyl; C2-C8 alkylsulfinylalkyl; C2-C8 alkylsulfonylalkyl; C4-C8 cycloalkylalkyl; C3-C8 trialkylsilyl; cyano; nitro; CO2Me; CO2Et; or NR11R12.
R7 is C1-C4 alkyl or C1-C4 haloalkyl;
R8 and R9 are each independently C2-C4 alkyl;
R10 and R11 are each independently H or C1-C4 alkyl; R12 is C1-C8 alkyl;
R8 and R10, or the groups R11 and R12, can be taken together to form -CH2CH2CH2CH2-, -CH2(CH2)3CH2-, -CH2CH2OCH2CH2-, -CH2CH(Me)CH2CH(Me)CH2-, or -CH2CH(Me)OCH(Me)CH2-; and R13 is halogen; C1-C4 alkyl, C1-C4 alkoxy, or C1-C4 haloalkyl;
provided that :
i) when Z is CR5=CR6, then at least one substituent selected from the group consisting of R3, R4, R5 and R6, is hydrogen; and
ii) the total number of carbons in R3, R4, R5 and R6 is equal to or less than 16; iϋ) the total number of nitrogen atoms
incorporated into the bicyclic
framework is less than or equal to four;
iv) R3 and R4 are not both hydrogen; and v) X and Y are not both nitrogen; and at least one of (a) a surfactant, (b) an organic solvent, and (c) at least one solid or liquid diluent.
7. A method for controlling plant diseases caused by fungal plant pathogens comprising applying to the plant or portion thereof to be protected, to the media in which the plant to be protected is growing, or to the plant seed or seedling to be protected an effective amount of a compound of Formula I
Figure imgf000059_0001
wherein:
Q is O or S;
W is O; S; S (O); S(O)2; NH; or NR9;
X is CR3 or N;
Y is CR4 or N; Z is CR5=CR6; CR5=N; N=CR6; S; O; or NR7; having the directionality of the CR5=CR6, CR5=N and N=CR6 linkages such that the moiety depicted on the left side of the double bond is bonded to Y and the moiety on the right side of the double bond is bonded to the ring junction;
R1 is C1-C18 alkyl; C3-C7 cycloalkyl; C2-C18
alkenyl; C2-C18 alkynyl; C1-C18 haloalkyl;
C2-C18 haloalkenyl; C2-C18 haloalkynyl; C2-C18 alkoxyalkyl; C2-C18 alkylthioalkyl; C2-C18 alkylsulfinylalkyl; C2-C18 alkylsulfonylalkyl; C4-C18 cycloalkylalkyl; C4-C18 alkenyloxyalkyl; C4-C18 alkynyloxyalkyl; C4-C18 cycloalkyloxyalkyl; C4-C18 alkenylthioalkyl; C4-C18 alkynylthioalkyl; C6-C18 cycloalkylthioalkyl; C2-C18 haloalkoxyalkyl; C3-C18 haloalkenyloxyalkyl; C4-C18 haloalkynyloxyalkyl; C4-C18 alkoxyalkenyl; C4-C18 alkoxyalkynyl; C4-C18 alkylthioalkenyl; C4-C18 alkylthioalkynyl; C4-C18
trialkylsilylalkyl; C1-C18 alkyl substituted with NR8R10, cyano, or nitro; C1-C8 alkyl substituted with CO2R8; C1-C18 alkoxy; C1-C18 haloalkoxy; C3-C18 alkynyloxy; C3-C18 alkenyloxy; C1-C18 alkylthio; C3-C18 alkenylthio; or C3-C18 alkynylthio;
R2 is C1-C18 alkyl; C3-C7 cycloalkyl; C3-C18
alkenyl; C3-C18 alkynyl; C1-C18 haloalkyl;
C3-C18 haloalkenyl; C3-C18 haloalkynyl; C2-C18 alkoxyalkyl; C2-C18 alkylthioalkyl; C2-C18 alkylsulfinylalkyl; C2-C18 alkylsulfonylalkyl;
C4-C18 cycloalkylalkyl; C4-C18 alkenyloxyalkyl; C4-C18 alkynyloxyalkyl; C4-C18 cycloalkyloxyalkyl; C4-C18 alkenylthioalkyl; C4-C18 alkynylthioalkyl; C6-C18 cycloalkylthioalkyl; C2-C18 haloalkoxyalkyl; C3-C18 haloalkenyloxyalkyl;
C4-C18 haloalkynyloxyalkyl; C4-C18 alkoxy alkenyl; C4-C18 alkoxyalkynyl; C4-C18 alkylthioalkenyl; C4-C18 alkylthioalkynyl; C4-C18 trialkylsilylalkyl; C1-C18 alkyl substituted with NR8R10; C2-C18 cyanoalkyl; C2-C18
nitroalkyl; C1-C8 alkyl substituted with CO2R8; or phenyl, benzyl, or phenethyl each optionally substituted on the phenyl ring with R13; or R1 and R2 can be taken together along with the
C=C-W fragment to which they are attached to form a 5-7 membered ring in which the R1-R2 bridge is a saturated, all-carbon chain
optionally substituted with C1-C12 alkyl;
R3 and R5 are each independently hydrogen; halogen;
C1-C4 alkyl; C1-C4 haloalkyl; C1-C4 alkoxy; or C1-C4 haloalkoxy;
R4 and R6 are each independently hydrogen; halogen;
C1-C8 alkyl; C3-C8 cycloalkyl; C2-C8 alkenyl; C2-C8 alkynyl; C1-C8 haloalkyl; C3-C8
haloalkenyl; C3-C8 haloalkynyl; C1-C8 alkoxy; C1-C8 haloalkoxy; C3-C8 alkenyloxy; C3-C8 alkynyloxy; C1-C8 alkylthio; C3-C8 alkenylthio; C3-C8 alkynylthio; C1-C8 alkylsulfinyl; C1-C8 alkylsulfonyl; C2-C8 alkoxyalkyl; C2-C8
alkylthioalkyl; C2-C8 alkylsulfinylalkyl; C2-C8 alkylsulfonylalkyl; C4-C8 cycloalkylalkyl;
C3-C8 trialkylsilyl; cyano; nitro; CO2Me;
CO2Et; or NR11R12;
R7 is C1-C4 alkyl or C1-C4 haloalkyl;
R8 and R9 are each independently C1-C4 alkyl;
R10 and R11 are each independently H or C1-C4 alkyl; R12 is C1-C8 alkyl;
R8 and R10, or the groups R11 and R12, can be taken together to form -CH2CH2CH2CH2-, -CH2(CH2)3CH2-, -CH2CH2OCH2CH2-, -CH2CH(Me)CH2CH(Me)CH2-, or -CH2CH(Me)OCH(Me)CH2-; and R13 is halogen; C1-C4 alkyl, C1-C4 alkoxy, or C1-C4 haloalkyl;
provided that:
i) when Z is CR5=CR6, then at least one substituent selected from the group consisting of R3, R4, R5 and R6, is hydrogen; and
ii) the total number of carbons in R3, R4, R5 and R6 is equal to or less than 16; iϋ) the total number of nitrogen atoms
incorporated into the bicyclic
framework is less than or equal to four;
iv) R3 and R4 are not both hydrogen; and v) X and Y are not both nitrogen; or
N-oxides or agriculturally suitable salts thereof.
8. A method for controlling plant diseases caused by fungal plant pathogens comprising applying to the plant or portion thereof to be protected, to the media in which the plant to be protected is growing, or to the plant seed or seedling to be protected an effective amount of a composition of Claim 6.
9. A method for controlling wheat powdery mildew comprising applying to the plant or portion thereof to be protected, to the media in which the plant to be protected is growing, or to the plant seed or seedling to be protected an effective amount of a compound of Claim 1.
10. A method for controlling wheat powdery mildew comprising applying to the plant or portion thereof to be protected, to the media in which the plant to be protected is growing, or to the plant seed or seedling to be protected an effective amount of a composition of Claim 6.
PCT/US1993/004188 1992-05-13 1993-05-10 Substituted pyrido[1,2-a]pyrimidinone derivatives as fungicides Ceased WO1993023398A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP93911028A EP0640083A1 (en) 1992-05-13 1993-05-10 Substituted pyrido 1,2-a]pyrimidinone derivatives as fungicides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88221592A 1992-05-13 1992-05-13
US07/882,215 1992-05-13

Publications (1)

Publication Number Publication Date
WO1993023398A1 true WO1993023398A1 (en) 1993-11-25

Family

ID=25380142

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/004188 Ceased WO1993023398A1 (en) 1992-05-13 1993-05-10 Substituted pyrido[1,2-a]pyrimidinone derivatives as fungicides

Country Status (3)

Country Link
EP (1) EP0640083A1 (en)
AU (1) AU4231293A (en)
WO (1) WO1993023398A1 (en)

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110178077A1 (en) * 2008-06-17 2011-07-21 Priscille Brodin Anti-infective compounds
CN103260407A (en) * 2010-12-27 2013-08-21 住友化学株式会社 Arthropod pest control composition and method for controlling arthropod pests
WO2013119916A3 (en) * 2012-02-10 2013-10-24 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
TWI489944B (en) * 2009-08-05 2015-07-01 Du Pont Mesoionic pesticides
US9371336B2 (en) 2012-03-01 2016-06-21 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
US9914722B2 (en) 2012-03-23 2018-03-13 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
US10195202B2 (en) 2013-12-19 2019-02-05 Ptc Therapeutics, Inc. Methods for modulating the amount of RNA transcripts
US10668171B2 (en) 2015-05-30 2020-06-02 Ptc Therapeutics, Inc. Methods for modulating RNA splicing
US10874672B2 (en) 2015-12-10 2020-12-29 Ptc Therapeutics, Inc. Methods for treating Huntington's disease
CN113214249A (en) * 2021-04-23 2021-08-06 成都大学 Synthesis method of pyrido [1,2-a ] pyrimidine-4-thioketone compound
US11382918B2 (en) 2017-06-28 2022-07-12 Ptc Therapeutics, Inc. Methods for treating Huntington's Disease
US11395822B2 (en) 2017-06-28 2022-07-26 Ptc Therapeutics, Inc. Methods for treating Huntington's disease
US11407753B2 (en) 2017-06-05 2022-08-09 Ptc Therapeutics, Inc. Compounds for treating Huntington's disease
US11608501B2 (en) 2017-06-14 2023-03-21 Ptc Therapeutics, Inc. Methods for modifying RNA splicing
US11685746B2 (en) 2018-06-27 2023-06-27 Ptc Therapeutics, Inc. Heteroaryl compounds for treating Huntington's disease
US11702646B2 (en) 2016-11-28 2023-07-18 Ptc Therapeutics, Inc. Methods for modulating RNA splicing
US11780839B2 (en) 2018-03-27 2023-10-10 Ptc Therapeutics, Inc. Compounds for treating Huntington's disease
US11858941B2 (en) 2018-06-27 2024-01-02 Ptc Therapeutics, Inc. Heterocyclic and heteroaryl compounds for treating Huntington's disease
CN118027024A (en) * 2022-11-14 2024-05-14 南京同诺康医药科技有限公司 Pyrido[1,2-a]pyrimidin-4-one derivatives and preparation methods and uses thereof
US12139499B2 (en) 2018-06-27 2024-11-12 Ptc Therapeutics, Inc. Heteroaryl compounds for treating Huntington's disease
CN118994154A (en) * 2024-08-13 2024-11-22 山西医科大学 C3 fluoroalkylation 4H-pyrido [1,2-a ] pyrimidine-4-ketone derivative and synthesis method thereof
US12473289B2 (en) 2019-11-25 2025-11-18 Amgen Inc. Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use
US12577226B2 (en) 2019-05-13 2026-03-17 Ptc Therapeutics, Inc. Compounds for treating Huntington's disease

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE621702A (en) * 1961-09-06 1962-12-17 Cutter Lab Pyridopyrimidone compounds
US3755582A (en) * 1971-03-04 1973-08-28 Du Pont Quinazolinone fungicides
CA1232904A (en) * 1984-03-26 1988-02-16 Adi M. Treasurywala Substituted pyrimidones with antifungal properties
EP0339105A1 (en) * 1986-10-28 1989-11-02 Nissan Chemical Industries Ltd. Nitrogen-containing heterocyclic compounds and compositions for controlling and/or preventing pests and blights (diseases)

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE621702A (en) * 1961-09-06 1962-12-17 Cutter Lab Pyridopyrimidone compounds
US3755582A (en) * 1971-03-04 1973-08-28 Du Pont Quinazolinone fungicides
CA1232904A (en) * 1984-03-26 1988-02-16 Adi M. Treasurywala Substituted pyrimidones with antifungal properties
EP0339105A1 (en) * 1986-10-28 1989-11-02 Nissan Chemical Industries Ltd. Nitrogen-containing heterocyclic compounds and compositions for controlling and/or preventing pests and blights (diseases)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 94, no. 2, 12 January 1981, Columbus, Ohio, US; abstract no. 15764s, '7-Alkoxythiazolo(3,2-a)pyrimidine derivatives' page 446 ; *
HELVETICA CHIMICA ACTA vol. 53, no. 5, 1970, BASEL CH pages 905 - 922 R. URBAN ET AL 'Alkylation des "malonyl-alpha-aminopyridines"' cited in the application *

Cited By (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011524391A (en) * 2008-06-17 2011-09-01 インスティチュート・パスツール・コリア Pyridopyrimidine compounds as antituberculosis agents
US20110178077A1 (en) * 2008-06-17 2011-07-21 Priscille Brodin Anti-infective compounds
US8785452B2 (en) 2008-06-17 2014-07-22 Institut National De La Sante Et De La Recherche Medicale Anti-infective compounds
AU2009267519B2 (en) * 2008-06-17 2014-11-27 Institut National De La Sante Et De La Recherche Medicale Pyridopyrimidine compounds as anti-tubercular agents
TWI489944B (en) * 2009-08-05 2015-07-01 Du Pont Mesoionic pesticides
CN103260407A (en) * 2010-12-27 2013-08-21 住友化学株式会社 Arthropod pest control composition and method for controlling arthropod pests
EP2658380A4 (en) * 2010-12-27 2014-05-28 Sumitomo Chemical Co Arthropod pest control composition and method for controlling arthropod pests
US9586955B2 (en) 2012-02-10 2017-03-07 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
EA029542B1 (en) * 2012-02-10 2018-04-30 ПиТиСи ТЕРАПЬЮТИКС, ИНК. 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE DERIVATIVES FOR TREATING SPINAL MUSCULAR ATROPHY
EA037123B1 (en) * 2012-02-10 2021-02-09 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Compounds for treating spinal muscular atrophy
WO2013119916A3 (en) * 2012-02-10 2013-10-24 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
JP2017122097A (en) * 2012-02-10 2017-07-13 ピーティーシー セラピューティクス, インコーポレイテッド Compounds for treating spinal muscular atrophy
US9879007B2 (en) 2012-02-10 2018-01-30 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
US11753407B2 (en) 2012-02-10 2023-09-12 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
JP2015508075A (en) * 2012-02-10 2015-03-16 ピーティーシー セラピューティクス, インコーポレイテッド Compounds for treating spinal muscular atrophy
US10851101B2 (en) 2012-02-10 2020-12-01 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
US9371336B2 (en) 2012-03-01 2016-06-21 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
US9914722B2 (en) 2012-03-23 2018-03-13 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
US10688099B2 (en) 2013-12-19 2020-06-23 Ptc Therapeutics, Inc. Methods for modulating the amount of RNA transcripts
US10195202B2 (en) 2013-12-19 2019-02-05 Ptc Therapeutics, Inc. Methods for modulating the amount of RNA transcripts
US10668171B2 (en) 2015-05-30 2020-06-02 Ptc Therapeutics, Inc. Methods for modulating RNA splicing
US11602567B2 (en) 2015-05-30 2023-03-14 Ptc Therapeutics, Inc. Methods for modulating RNA splicing
US10881658B2 (en) 2015-12-10 2021-01-05 Ptc Therapeutics, Inc. Methods for treating Huntington's disease
US11638706B2 (en) 2015-12-10 2023-05-02 Ptc Therapeutics, Inc. Methods for treating Huntington's disease
US10874672B2 (en) 2015-12-10 2020-12-29 Ptc Therapeutics, Inc. Methods for treating Huntington's disease
US11702646B2 (en) 2016-11-28 2023-07-18 Ptc Therapeutics, Inc. Methods for modulating RNA splicing
US12384789B2 (en) 2017-06-05 2025-08-12 Ptc Therapeutics, Inc. Compounds for treating Huntington's disease
US11407753B2 (en) 2017-06-05 2022-08-09 Ptc Therapeutics, Inc. Compounds for treating Huntington's disease
US11608501B2 (en) 2017-06-14 2023-03-21 Ptc Therapeutics, Inc. Methods for modifying RNA splicing
US11382918B2 (en) 2017-06-28 2022-07-12 Ptc Therapeutics, Inc. Methods for treating Huntington's Disease
US11395822B2 (en) 2017-06-28 2022-07-26 Ptc Therapeutics, Inc. Methods for treating Huntington's disease
US11780839B2 (en) 2018-03-27 2023-10-10 Ptc Therapeutics, Inc. Compounds for treating Huntington's disease
US12103926B2 (en) 2018-03-27 2024-10-01 Ptc Therapeutics, Inc. Compounds for treating huntington's disease
US11858941B2 (en) 2018-06-27 2024-01-02 Ptc Therapeutics, Inc. Heterocyclic and heteroaryl compounds for treating Huntington's disease
US11685746B2 (en) 2018-06-27 2023-06-27 Ptc Therapeutics, Inc. Heteroaryl compounds for treating Huntington's disease
US12139499B2 (en) 2018-06-27 2024-11-12 Ptc Therapeutics, Inc. Heteroaryl compounds for treating Huntington's disease
US12577226B2 (en) 2019-05-13 2026-03-17 Ptc Therapeutics, Inc. Compounds for treating Huntington's disease
US12473289B2 (en) 2019-11-25 2025-11-18 Amgen Inc. Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use
CN113214249A (en) * 2021-04-23 2021-08-06 成都大学 Synthesis method of pyrido [1,2-a ] pyrimidine-4-thioketone compound
CN113214249B (en) * 2021-04-23 2023-09-19 成都大学 Synthesis method of pyrido [1,2-a ] pyrimidine-4-thioketone compound
CN118027024A (en) * 2022-11-14 2024-05-14 南京同诺康医药科技有限公司 Pyrido[1,2-a]pyrimidin-4-one derivatives and preparation methods and uses thereof
CN118994154A (en) * 2024-08-13 2024-11-22 山西医科大学 C3 fluoroalkylation 4H-pyrido [1,2-a ] pyrimidine-4-ketone derivative and synthesis method thereof

Also Published As

Publication number Publication date
AU4231293A (en) 1993-12-13
EP0640083A1 (en) 1995-03-01

Similar Documents

Publication Publication Date Title
EP0836602B1 (en) Fungicidal pyrimidinones
US5747497A (en) Fungicidal fused bicyclic pyrimidinones
WO1993023398A1 (en) Substituted pyrido[1,2-a]pyrimidinone derivatives as fungicides
AU677448B2 (en) Fungicidal cyclic amides
WO1998026664A1 (en) Fungicidal quinazolinones
EP0642502B1 (en) Fungicidal imidazolinones
WO1993022311A1 (en) Fungicidal 1,3,4-oxadiazines and 1,3,4-thiadiazines
WO1996026191A1 (en) Fungicidal cyclic amides
EP0632803B1 (en) Arthropodicidal amides
EP0623125A1 (en) Bridged heterocyclic fungicides
WO2000051992A1 (en) Fused bicyclic oxazinone and thiazinone fungicides
EP0630370A1 (en) Fungicidal oxazolidinones
WO1992019615A2 (en) Fungicidal pyrazoles, pyrazolines and tetrahydropyridazines
WO2000008026A2 (en) Fungicidal fused bicyclic heterocycles
WO1999011129A1 (en) Enantiomerically enriched compositions and their pesticidal use
EP0869963A1 (en) Arthropodicidal and fungicidal organosilanes and organogermanes
EP0937051A1 (en) Fungicidal cyclic amides
US6255311B1 (en) Fungicidal fused bicyclic pyrimidinones
USH1829H (en) Fungicidal fused bicyclic pyrimidinones
US5514678A (en) Arthropodicidal 1,2,4-triazinyl amides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BB BG BR CA CZ FI HU JP KP KR KZ LK MG MN MW NO NZ PL RO RU SD SK UA US VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
EX32 Extension under rule 32 effected after completion of technical preparation for international publication

Ref country code: BY

LE32 Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b)

Ref country code: BY

WWE Wipo information: entry into national phase

Ref document number: 1993911028

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1993911028

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1993911028

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA